[Search',  ', Images',  ', Maps',  ', Play',  ', YouTube',  ', News',  ', Gmail',  ', Drive',  ', More',  »', Help',  | ', Sign in', u"
(function() {
  var l = window.location;
  var q = l.search ? l.search.substr(1) : '';
  var h = l.hash ? l.hash.substr(1) : '';
  var p = '/finance';
  var ss = 'stockscreener';
  var conn = window.history && window.history.pushState ? '/' : '#';
  if (l.pathname == p + '/' + ss) {
    if (h) l.href = p + conn + ss + '?' + q + '&' + h;
  } else if (l.pathname != p && h) {
    l.href = p + l.hash;
  }
  if (h) {
document.getElementById('fjfe-click-wrapper').style.display = 'none';
  }
})();
", Company', Summary', News', Related companies', Historical prices', Markets', News', Portfolios', Stock screener', Google Domestic Trends', Recent Quotes ', (', 30 days', )', You have no recent quotes', chg',  | ', %', u"var _cleardot = 'data:image\/gif;base64,R0lGODlhAQABAIAAAP\/\/\/\/\/\/\/yH5BAEKAAEALAAAAAABAAEAAAICTAEAOw\x3d\x3d';
    var google = google || {};
    google.finance = google.finance || {};
    google.finance.gce = false ;", u"
      _regOnLoad = function(f) {
        if (document.readyState == 'complete') {
          f && f();
        } else {
          // Window.attachEvent() for IE8 and below compatability.
          var addEventFunction = window.attachEvent ||
              window.addEventListener || function(ignored, f) { f(); };
          var event = window.attachEvent ? 'onload' : 'load';
          f && addEventFunction(event, f);
        }
      };
    
      google.finance.renderRecentQuotes = function() {};
    ", 
', 
(function() {
if (window['_finance_chart']) {
var el = document.getElementById('chart_anchor');
if (el) {
el.innerHTML = '';
}
setFinanceChart(null);
}
})();
var _ticker = 'NSE:APLLTD';
var _slHeight = 221;
var _companyName = 'Alembic Pharmaceuticals Ltd';
var _companyPageNewsTab = '0';
var _displayVolume = true;
setCompanyId(1402851);
_s_Store._numToDisplay = 6;
_comparison_charts_Store._numToDisplay = 8;
_comparison_charts_Store._allowMultiTimezoneCompare = true;
function onCompanyLoad() {
_external_target = "";
_emitFlashChartOnLoad(
"/finance/s/n-VxNKK74DU/chart9.swf?hl=en&gl=us",
_ticker, "chart_anchor", "market-data-div",
_chartConfigObject);
google.finance.onCompanyLoad();
_initAutoFocus();
if (google.finance.initTechnicals) {
google.finance.initTechnicals(true);
}
}
', 
', 
', 
', 
', Alembic Pharmaceuticals Ltd  ', (Public, NSE:APLLTD)  
', Watch this stock', 
 
', 
', 
', 
', 

', 
_ac_register(function (input, event) {
if (input.id == 'add_comparison_symbol') {
_comparison_charts_Store.baseTicker = "NSE:APLLTD";
return _comparison_charts_Store;
}
});
var _prefs=_prefs||{};_prefs.hash="";
_prefs.feeds=_prefs.feeds||{};
_prefs.ch=_prefs.ch||{};
_prefs.ch_compare=_prefs.ch_compare||{};
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = 'WJ5rWOGGHZPYuATI5a2wAw';
var _expid;
var _external_target;
var _localDomain = 'www.google.com';
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
var google = google || {};
google.finance = google.finance || {};
google.finance.data = {common:{rq:{ct:""},up:"chg",down:"chr",linktargetInternal:"",hash:"",dfp:"ad-g.doubleclick.net/adi/com.gf.company/default;fe=nse;ft=aplltd;fm=large;dcopt=ist;myd=ad;sz=300x250;tile=1",streaming:[{cid:"1402851",s:"APLLTD",e:"NSE"},{cid:"13475323",s:"ALEMBICLTD",e:"NSE"},{cid:"6286747",s:"506260",e:"BOM"},{cid:"8321085",s:"530317",e:"BOM"},{cid:"16520755",s:"INDSWFTLTD",e:"NSE"},{cid:"5262084",s:"MARKSANS",e:"NSE"},{cid:"10147154",s:"NATCOPHARM",e:"NSE"},{cid:"13313409",s:"GLAXO",e:"NSE"},{cid:"3578659",s:"DRREDDY",e:"NSE"},{cid:"2456500",s:"WANBURY",e:"NSE"},{cid:"16546949",s:"531633",e:"BOM"}],dfp_companion:"ad-g.doubleclick.net/adi/com.gf.company/default;fe=nse;ft=aplltd;fm=large;dcopt=ist;myd=ad2;sz=33x33;tile=2"},company:{news:{clusters:[{nrel:1,idx:0,id:"52779294660048",lead_story_url:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html",a:[{t:"Alembic Pharmaceuticals Ltd drops 1.23%",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets.",d:"Dec 5, 2016",tt:"1480941346",usg:"AFQjCNFQUS6QsEDuCFDPJSkYyd673AIw2Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html\u0026cid=52779294660048\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGaK5XFGRssXGjUcC31SUu5nwFGLg"}],lead_story_doc_id:"18009592219006405310"},{idx:1,id:"0",lead_story_url:"http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals",a:[{t:"Alembic Pharmaceuticals",u:"http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals",s:"Pharmacy Times",sp:"Alembic Pharmaceuticals, Inc., is a subsidiary of Alembic Pharmaceuticals, Ltd., the oldest pharmaceutical company in India.",d:"Aug 25, 2016",tt:"1472156100",usg:"AFQjCNEiGxi_dGt-HphEg0uWlGS50Q599g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNG0o9bUaqFTTJLgtxX9EySPkmwFlw"}],lead_story_doc_id:"15168226560533480914"},{nrel:92,idx:2,id:"52779169893848",lead_story_url:"http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html",a:[{t:"We are planning 6-8 new launches this fiscal yr: Alembic Pharma",u:"http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html",s:"Moneycontrol.com",sp:"Speaking to CNBC-TV18 Pranav Amin, Managing Director of Alembic Pharmaceuticals, said that good Q1 numbers were led by international business.",d:"Jul 29, 2016",tt:"1469783132",usg:"AFQjCNFBfxeyfat9dZJhp0UFYl2JlsVM1Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html\u0026cid=52779169893848\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFHMEkCV9yTvWGDiVS5tUBYAb6E2Q"},{t:"Alembic Pharma Q1 net jumps 45%",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-q1-net-jumps-45/article8916824.ece",s:"Hindu Business Line",sp:"Vadodara-based Alembic Pharmaceuticals Ltd has posted a net profit of Rs. 102 crore for the first quarter ended June 30, 2016, showing 45 per cent rise over Rs.",d:"Jul 29, 2016",tt:"1469783475",usg:"AFQjCNGFlHnSxVjNozaiaJvW_OezjqzVKQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-q1-net-jumps-45/article8916824.ece\u0026cid=52779169893848\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEDznjUFLsYThkV54-kzILCj-4GtA"}],lead_story_doc_id:"9928500749914579245"},{nrel:22,idx:3,id:"52779036893604",lead_story_url:"http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html",a:[{t:"Alembic Pharma Q3 profit jumps 281% to Rs 270 cr on US exports",u:"http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html",s:"Moneycontrol.com",sp:"Alembic Pharmaceuticals has reported solid earnings performance during October-December quarter with consolidated profit rising massive 281.2 percent year-on-year to Rs 269.5 crore on US business.",d:"Jan 21, 2016",tt:"1453370248",usg:"AFQjCNFgE5LYKZ0vH5IvABiBX3c776f4Aw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html\u0026cid=52779036893604\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEoeHzLMyJN7dmDvPsTnBvrx7dFdw"},{t:"Alembic Pharma gains on strong Q3 results",u:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-strong-q3-results-116012100538_1.html",s:"Business Standard",sp:"Alembic Pharmaceuticals has surged 7% to Rs 631 on the BSE after the company reported nearly four-fold jump in consolidated net profit at Rs 269 crore for the quarter ended December 2015 (Q3FY16) on back of strong growth in international business.",d:"Jan 21, 2016",tt:"1453367848",usg:"AFQjCNHQ5t3JVS7wQQQxVJE-K9HyYQX-9g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-gains-on-strong-q3-results-116012100538_1.html\u0026cid=52779036893604\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH_IpLwT71_PxKMEg4AfuBWY37VtQ"}],lead_story_doc_id:"11300447456109101484"},{nrel:2,idx:4,id:"52779275598593",lead_story_url:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece",a:[{t:"Alembic Pharma gets USFDA approval for anti-hypertension drug",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece",s:"Hindu Business Line",sp:"Vadodara-based drug player Alembic Pharmaceuticals Ltd has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Telmisartan and Amlodipine Tablets.",d:"Nov 19, 2016",tt:"1479552075",usg:"AFQjCNGp90G_sQKCEgKZy5Vl_YJFQnEcLQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece\u0026cid=52779275598593\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGQB3YwExVl__J2jgn-e9XmLpzJUA"}],lead_story_doc_id:"14767591891315490170"},{nrel:2,idx:5,id:"52779100506485",lead_story_url:"http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/",a:[{t:"Panama Papers: Amins of Alembic set up BVI firm to buy and rent London property",u:"http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/",s:"The Indian Express",sp:"Alembic Pharmaceuticals Ltd promoter Chirayu Amin and his family members - Malika Amin, Pranav Amin, Shaunak Amin and Udit Amin - are listed as beneficiaries of Whitefield Global Investments Ltd, which was incorporated in the British Virgin Islands\u0026nbsp;...",d:"May 5, 2016",tt:"1462491455",usg:"AFQjCNEjAEY00QTE3w5y5yIrgkQQ9_kfRQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/\u0026cid=52779100506485\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFN_P1iNgyLWcmRXIdUc1056T4j-Q"},{t:"Alembic Pharma\u0026#39;s Chirayu Amin, family set up offshore firm in 2015, Panama ...",u:"http://www.dnaindia.com/money/report-alembic-pharma-s-chirayu-amin-family-set-up-offshore-firm-in-2015-panama-papers-reveal-2209728",s:"Daily News \u0026 Analysis",sp:"Vadodara-based Alembic Pharmaceuticals\u0026#39; promoter Chirayu Amin set up an offshore entity in the British Virgin Islands (BVI) in 2015, a report in The Indian Express has said.",d:"May 6, 2016",tt:"1462512147",usg:"AFQjCNEXFy74upbdKD60G4tZYdJmu-vE_A",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.dnaindia.com/money/report-alembic-pharma-s-chirayu-amin-family-set-up-offshore-firm-in-2015-panama-papers-reveal-2209728\u0026cid=52779100506485\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHfJGw4h4qvvWGNrXw3Br-aLBRhlg"}],lead_story_doc_id:"13257896125845329274"},{nrel:16,idx:6,id:"52779091595714",lead_story_url:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html",a:[{t:"Alembic Pharma gains on JV with Orbicular",u:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html",s:"Business Standard",sp:"&#8220;APL has entered into joint venture agreement dated 20th April, 2016 with Orbicular Pharmaceutical Technologies Private Limited (Orbicular) and Dr M S Mohan to develop, manufacture and commercialize dermatology products for global markets,&#8221; APL said\u0026nbsp;...",d:"Apr 21, 2016",tt:"1461219247",usg:"AFQjCNEITmY254QSQ0MALwgoP5LTmTid1A",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH5yM1BzFm3HfRWsI2YtYYAy__52A"},{t:"Alembic to float joint venture with Orbicular Pharma",u:"http://www.thehindubusinessline.com/companies/alembicorbicular-pharma-venture-to-develop-make-dermatology-products/article8503551.ece",s:"Hindu Business Line",sp:"Alembic Pharmaceuticals Ltd today said it has entered into a joint venture with Orbicular Pharmaceutical Technologies and Dr MS Mohan to develop, manufacture and commercialise dermatology products for global markets.",d:"Apr 21, 2016",tt:"1461219075",usg:"AFQjCNFzLGEBZVPiXQdY4DzAhPlaqQkgrA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembicorbicular-pharma-venture-to-develop-make-dermatology-products/article8503551.ece\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGUMsGfIK6BhSJvNkc5BxhwRVnPVQ"},{t:"Alembic Pharma forms JV with Orbicular",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-forms-jv-with-orbicular-116042100312_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals. Alembic Pharma has announced that it has formed 60:40 JV with Orbicular to develop \u0026amp; commercialise Derma products.",d:"Apr 21, 2016",tt:"1461215700",usg:"AFQjCNEpeL2JTuXhgp2Ke-Wf7lPKwnSGpg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharma-forms-jv-with-orbicular-116042100312_1.html\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGDzRvgOXv3ONhQBtLrppTHUgLu6Q"}],lead_story_doc_id:"5602090657821206911"},{idx:7,id:"0",lead_story_url:"http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece",a:[{t:"Alembic Pharma: Right prescription",u:"http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece",s:"Hindu Business Line",sp:"Alembic Pharmaceuticals, which was spun off following the demerger of the pharmaceuticals business from Alembic Limited in April 2010, has been doing quite well, especially in its key US market which contributes nearly half of its revenues. First, the ...",d:"Aug 20, 2016",tt:"1471708575",usg:"AFQjCNGTNViejGLMuvARteOkWW6ad0P6Kw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH1IUtc323kicln5v22Q39eWPf79A"}],lead_story_doc_id:"464119262658413092"},{nrel:8,idx:8,id:"52779096444421",lead_story_url:"http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html",a:[{t:"Alembic Pharma net profit up 30%",u:"http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html",s:"Livemint",sp:"Hyderabad: Alembic Pharmaceuticals Ltd on Wednesday said its net profit rose 30% in the quarter ended March on the back of a strong performance by its international formulations and active ingredients businesses.",d:"Apr 27, 2016",tt:"1461765150",usg:"AFQjCNGngmKzEOjXJr0iVNWKVzoA0NGWHg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html\u0026cid=52779096444421\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF1YAnNxKhfyCcEeAaQYJgCVx4g2g"},{t:"Alembic Pharma posts net profit of Rs 719 crores for quarter ending March 31, 2016",u:"http://www.financialexpress.com/article/pharma/latest-updates/alembic-pharmaceuticals-posts-net-profit-of-rs-719-crores-for-quarter-ending-march-31-2016/244444/",s:"Financial Express",sp:"Pranav Amin, Managing Director, Alembic Pharmaceuticals, &#8220;This has been an outstanding year for the company. R\u0026amp;D will continue to remain a thrust area and we hope to strengthen our portfolio rapidly in the years to come.",d:"Apr 28, 2016",tt:"1461825225",usg:"AFQjCNGzkDTYtBXidLuK32xFTTQG10OMww",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.financialexpress.com/article/pharma/latest-updates/alembic-pharmaceuticals-posts-net-profit-of-rs-719-crores-for-quarter-ending-march-31-2016/244444/\u0026cid=52779096444421\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHqlD6TwdmfMv-D9L3wE3A9k8hK_w"}],lead_story_doc_id:"5093585876226575353"},{nrel:6,idx:9,id:"52779233152487",lead_story_url:"http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms",a:[{t:"Alembic Pharma receives EIR report from USFDA",u:"http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms",s:"Economic Times",sp:"\u0026quot;The company\u0026#39;s formulation facility located at Panelav has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (FDA) for the inspection carried out by them in March 2016,\u0026quot; Alembic Pharmaceuticals said in a BSE filing.",d:"Oct 5, 2016",tt:"1475659771",usg:"AFQjCNGXO1OBg1qQDNal9fQvEMyFYRKkFg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms\u0026cid=52779233152487\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGgcNAEakool99L4Qaas1SHo4Sa9w"}],lead_story_doc_id:"10095635002404126976"},{nrel:17,idx:10,id:"52779098838518",lead_story_url:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece",a:[{t:"Alembic Pharma gets USFDA nod for lacosamide tablets",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece",s:"Hindu Business Line",sp:"Vadodara-based drug maker Alembic Pharmaceuticals Ltd has informed that the company has received final approval from the US drug regulator - US Food and Drug Administration (USFDA) for its Lacosamide tablets, which is indicated as adjunctive therapy\u0026nbsp;...",d:"May 2, 2016",tt:"1462183650",usg:"AFQjCNF2ZjBBOqOZl_TZVxyd8-FtVELLog",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece\u0026cid=52779098838518\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNE-L4lIPuNej7L91VG5iAaEpAbJsQ"},{t:"Alembic Pharmaceuticals gets USFDA approval for Lacosamide Tablets",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-gets-usfda-approval-for-lacosamide-tablets-116050200095_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals has received final approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Tablets, SO mg, 100 mg, lSO mg and 200 mg.",d:"May 2, 2016",tt:"1462170639",usg:"AFQjCNF7MXxe30c9BtQkxQDsMdjYWruvTQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-gets-usfda-approval-for-lacosamide-tablets-116050200095_1.html\u0026cid=52779098838518\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHQE-xgjRvDSTJsWObtys612Y4PKw"}],lead_story_doc_id:"17622716464232799505"},{nrel:3,idx:11,id:"52779275114613",lead_story_url:"http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html",a:[{t:"Alembic Pharmaceuticals gets USFDA Approval for Telmisartan and Amlodipine Tablets",u:"http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited today announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Telmisartan and Amlodipine Tablets, 40 mg/5 mg, 40 mg/10\u0026nbsp;...",d:"Nov 18, 2016",tt:"1479468375",usg:"AFQjCNFcR4VqxtgI0uR-7DWJNjbTO3A7Eg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html\u0026cid=52779275114613\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHocicZRGTFX2pCS4uO4LrIzCZXvQ"},{t:"Alembic Pharmaceuticals receives FDA approval for hypertension tablets",u:"https://rtn.asia/d-n/25021/alembic-pharmaceuticals-receives-fda-approval-hypertension-tablets",s:"Real Time News, India",sp:"Alembic Pharmaceuticals Ltd said it received approval from the United States Food \u0026amp; Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.",d:"Nov 18, 2016",tt:"1479469498",usg:"AFQjCNEXJrj0LEG20KBB9ISDNIUBqyVXrw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=https://rtn.asia/d-n/25021/alembic-pharmaceuticals-receives-fda-approval-hypertension-tablets\u0026cid=52779275114613\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGy-WXRVw_oHt5g7hCuA9-iRPoCPw"}],lead_story_doc_id:"4767819221078404609"},{nrel:6,idx:12,id:"52779260096544",lead_story_url:"http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html",a:[{t:"Hold Alembic Pharmaceuticals; target of Rs 700: Axis Direct",u:"http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html",s:"Moneycontrol.com",sp:"Alembic is in a sweet spot given ramp-up on small US revenue base, lower USFDA risks (as facilities recently cleared by USFDA), steady India business and strong return ratios.",d:"Nov 1, 2016",tt:"1478001439",usg:"AFQjCNHpchGt31DnO_JTeHjOSRmI5mQq-g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html\u0026cid=52779260096544\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGTV3t7Ym7f1O_UY57eQnkwxs3lHg"}],lead_story_doc_id:"311637444421722264"},{nrel:4,idx:13,id:"52779308059670",lead_story_url:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html",a:[{t:"Alembic Pharma gets USFDA approval for ltraconazole Capsules; Stock jumps 0.7%",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ltraconazole Capsules, 100 mg.",d:"Dec 16, 2016",tt:"1481868675",usg:"AFQjCNEt5iuauIN0AN4Ycm8MWes5R3G3Ng",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html\u0026cid=52779308059670\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEh8YvkH6Jrn7quhe6Zjvd5WlFgug"},{t:"Alembic receives USFDA approval for Itraconazole capsules",u:"http://www.moneycontrol.com/news/business/alembic-receives-usfda-approval-for-itraconazole-capsules_8126981.html",s:"Moneycontrol.com",sp:"Alembic receives USFDA approval for Itraconazole capsules. Alembic Pharmaceuticals Ltd today announced that the company has received approval from US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for\u0026nbsp;...",d:"Dec 16, 2016",tt:"1481889295",usg:"AFQjCNGA-m5giPTTzKMhWLHe7vsfhiDPGg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/business/alembic-receives-usfda-approval-for-itraconazole-capsules_8126981.html\u0026cid=52779308059670\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGvFSRARA-zJWZrgch0Ck7YDDe_Hw"}],lead_story_doc_id:"2746521445400611360"},{idx:14,id:"0",lead_story_url:"http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html",a:[{t:"Checkout: SP Tulsian\u0026#39;s views on Dish TV, Alembic Pharma, sugar",u:"http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html",s:"Moneycontrol.com",sp:"Sonia: From the pharma space Alembic Pharma is one stock I wanted to ask you about because you had been bullish on that stock for a while and the numbers look quite good for the company, a profit of growth of almost 50 percent, is this the stock that ...",d:"Jul 29, 2016",tt:"1469801701",usg:"AFQjCNFJXyjGiWv9KVWknNIOLGfGFlC6yQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEjCb1RyzH7j6yy3mcLPGRwUHi3kQ"}],lead_story_doc_id:"15702015986716663660"},{idx:15,id:"0",lead_story_url:"http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html",a:[{t:"ICICI Sec initiates coverage on Alembic Pharma with add rating",u:"http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html",s:"Moneycontrol.com",sp:"Alembic Pharma is a vertically integrated pharmaceutical company with major focus on formulations business in India and US.",d:"Jul 18, 2016",tt:"1468835100",usg:"AFQjCNEsCrfh_11CQQvHx2M2qE0djLMpjw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEGL7d_u2JnS3jDqLY9GnxzId8w4w"}],lead_story_doc_id:"18045412946307932939"},{nrel:19,idx:16,id:"52779152501720",lead_story_url:"http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html",a:[{t:"Alembic Pharma, Cadila Healthcare gain on getting EIR from USFDA",u:"http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html",s:"Business Standard",sp:"Shares of Alembic Pharmaceuticals and Cadila Healthcare have rallied by up to 8% on the BSE in intra-day trade after these companies announced that they have received Establishment Inspection Report (EIR) from that US Food and Drug Administration\u0026nbsp;...",d:"Jul 8, 2016",tt:"1467966296",usg:"AFQjCNGkQK9KdxWQMj91EpDnpOSGdoU7ZA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html\u0026cid=52779152501720\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGZbSf6wmEzOnQ8jhXQw8RDAo243A"},{t:"Alembic Pharma shares surge over 7 per cent as Gujarat API unit gets USFDA EIR",u:"http://www.financialexpress.com/market/indian-markets/alembic-pharma-shares-on-bse-sensex-nse-nifty-on-july-8-2016/310525/",s:"Financial Express",sp:"Alembic Pharmaceuticals Ltd shares surged over 7 per cent intraday on Friday after the company said that it has received Establishment Inspection Report (EIR) from USFDA for the inspection carried out its Karakhadi API Plant III in April, 2015.",d:"Jul 8, 2016",tt:"1467965700",usg:"AFQjCNFYlApkTOtnEsQm1vu8rBpIk28vlg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.financialexpress.com/market/indian-markets/alembic-pharma-shares-on-bse-sensex-nse-nifty-on-july-8-2016/310525/\u0026cid=52779152501720\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF41nzOrX691jQKcZ_rhqXUIONu1Q"}],lead_story_doc_id:"17893708038863782210"},{idx:17,id:"0",lead_story_url:"http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1",a:[{t:"How the Amin family scions changed Alembic\u0026#39;s fortunes",u:"http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1",s:"Forbes India",sp:"Though the group\u0026#39;s real estate venture has nothing to do with its flagship listed pharmaceuticals business, the towering vertical structures are metaphoric of the equally vertical growth exhibited by Alembic Pharmaceuticals Ltd &#8212;one of India\u0026#39;s fastest ...",d:"Aug 4, 2016",tt:"1470277472",usg:"AFQjCNFC4JwxLAMWUTx5ovB5SZ74khTATQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHagFzFQfwq9jhTWk9Vu52ZKijedA"}],lead_story_doc_id:"17410343117097814001"},{idx:18,id:"0",lead_story_url:"http://www.equitybulls.com/admin/news2006/news_det.asp?id=197079",a:[{t:"Alembic Pharmaceuticals receives USFDA Approval for Zolmitriptan Orally ...",u:"http://www.equitybulls.com/admin/news2006/news_det.asp?id=197079",s:"Equity Bulls",sp:"Alembic Pharmaceuticals Limited has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg.",d:"Dec 6, 2016",tt:"1480997444",usg:"AFQjCNHqoXIqGwqFMf9U5U4oyQezVOYhiA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.equitybulls.com/admin/news2006/news_det.asp%3Fid%3D197079\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNElDVWoZNNn_7ri_0t8O945HPr5TA"}],lead_story_doc_id:"3225528078968639210"},{nrel:1,idx:19,id:"52779244595433",lead_story_url:"http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html",a:[{t:"Sebi clarifies on re-classification of promoter group",u:"http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html",s:"Livemint",sp:"Expressing its views on an application filed by Alembic Pharmaceutical Ltd, the regulator said such re-classification may be allowed by the stock exchanges under listing norms subject to certain compliances.",d:"Oct 17, 2016",tt:"1476722475",usg:"AFQjCNFBmnESrPP9_mrh7KO6MujbwgwR9w",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html\u0026cid=52779244595433\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFj7WABzJRFWyKYwi7k3YgFNwPHVw"}],lead_story_doc_id:"10360916528757987895"},{nrel:1,idx:20,id:"52779280720590",lead_story_url:"http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1",a:[{t:"Pranav \u0026amp; Shaunak Amin: Living up to Alembic Pharma\u0026#39;s legacy",u:"http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1",s:"Forbes India",sp:"In 2010, the pharma business was carved out of Alembic Ltd, which is still listed on the bourses as an entity that houses the group\u0026#39;s real estate business.",d:"Nov 23, 2016",tt:"1479874121",usg:"AFQjCNGFirYqcsbnzdPkO4HUJjlsBs-uRg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1\u0026cid=52779280720590\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHMoy3kuoflX_-qT7kaQfXxP-TRjw"}],lead_story_doc_id:"4074195192213512356"},{nrel:30,idx:21,id:"52779316719959",lead_story_url:"http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/",a:[{t:"Vadodara liquor party: Ex-IPL chairman Chirayu Amin among 261 booked",u:"http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/",s:"The Indian Express",sp:"A high profile pre-marriage liquor party at a farmhouse on the city outskirts was raided late on Thursday night and 261 people, including former IPL Chairman and Managing Director of the Alembic Pharmaceutical Ltd Chirayu Amin, were booked in this\u0026nbsp;...",d:"Dec 23, 2016",tt:"1482531525",usg:"AFQjCNFWU5df0Opc9Zr-p1_WEMwNnCvadA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGlaGonbVcDJAhYNB3T1xIZJp5LWQ"},{t:"Business leaders detained for consuming liquor in Gujarat",u:"http://www.thehindubusinessline.com/news/national/exipl-chief-business-leaders-detained-for-consuming-liquor-in-gujarat/article9442002.ece",s:"Hindu Business Line",sp:"The Vadodara rural police raided a farmhouse on the outskirts and detained 261 persons, including Chirayu Amin, former chairman of Indian Premiere League (IPL) and chairman of pharma player, Alembic Pharmaceuticals Ltd besides other leading\u0026nbsp;...",d:"Dec 23, 2016",tt:"1482496425",usg:"AFQjCNFDsmFnigNWnPIYOLkCgr5ABBv6MQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/news/national/exipl-chief-business-leaders-detained-for-consuming-liquor-in-gujarat/article9442002.ece\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGbKiwyonv3bVjTJQ--vgLcYhnj-w"},{t:"Police busts booze party near Vadodara, 261 including former IPL chairman booked",u:"http://www.indiatvnews.com/news/india-police-busts-booze-party-near-vadodara-261-including-former-ipl-chairman-booked-362322",s:"India TV",sp:"Acting on a tip-off, Vadodara police on Thursday busted a pre-marriage booze party and 261 people, including former IPL Chairman and Managing Director of the Alembic Pharmaceutical Ltd Chirayu Amin, were booked in this connection. Among others\u0026nbsp;...",d:"Dec 24, 2016",tt:"1482570000",usg:"AFQjCNHp6DaILnE0fvxAit76P8o6vGgkXA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiatvnews.com/news/india-police-busts-booze-party-near-vadodara-261-including-former-ipl-chairman-booked-362322\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHYvahRQof9Zf1xEpJqJqIx1l0xzw"}],lead_story_doc_id:"16905264914339455772"},{idx:22,id:"0",lead_story_url:"http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine",a:[{t:"Biggies bite dust, small firms shine | Ahmedabad NYOOOZ",u:"http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine",s:"NYOOOZ",sp:"Top corporates such as Adani Enterprises Ltd (AEL), Adani Power, Torrent Pharmaceuticals Ltd, Tor rent Power Ltd, Alembic Pharmaceuticals Ltd and Arvind Ltd offered negative returns to their shareholders.Share prices of Adani Ports and Special Economic\u0026nbsp;...",d:"Jan 2, 2017",tt:"1483336606",usg:"AFQjCNGid5ZMAFlyfKLaB7IESwDqV4iR5Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHZ4J4k9hCAXnsffyZhHM8PYmas0g"}],lead_story_doc_id:"9469653977539435813"},{idx:23,id:"0",lead_story_url:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html",a:[{t:"Pharmaceuticals Newsletter - December 12 to 16, 2016",u:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ltraconazole Capsules, 100 mg.",d:"Dec 16, 2016",tt:"1481890275",usg:"AFQjCNGkVv3Z9gyAs89sBw8tuMtm06rVrg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF708BPlqBKfvcwONEC8OtkT7y55Q"}],lead_story_doc_id:"5325849731044066663"},{nrel:14,idx:24,id:"52779306708017",lead_story_url:"https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr",a:[{t:"Cipla redraws Iran plans with new agreement, to invest Rs 121 cr",u:"https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr",s:"Real Time News, India",sp:"Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.",d:"Dec 15, 2016",tt:"1481770800",usg:"AFQjCNHnJomc2mjNKhQVaQMdFOIW0tvOmQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr\u0026cid=52779306708017\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGrHKFDsM4_Tk2O9oehtIamb68u6Q"}],lead_story_doc_id:"14492314507761336533"},{idx:25,id:"0",lead_story_url:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html",a:[{t:"Pharmaceuticals Newsletter - December 05 to 08, 2016",u:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg.",d:"Dec 9, 2016",tt:"1481288133",usg:"AFQjCNGZ5R772ytzsJESXsXGtIw4TxQNQg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNES1WpE38zyCUFLjZipgT-R1xCDWQ"}],lead_story_doc_id:"1558386962020854717"},{idx:26,id:"-1"}],results_per_page:10,result_start_num:1,result_end_num:0,result_total_articles:34},related:{cols:[0,1,4,30,34,31,32,5,2,33,3],rows:[{id:"1402851",values:["APLLTD","Alembic Pharmaceuticals Ltd","602.00","+0.50","chg","0.08","","113.71B","NSE","1402851","APLLTD"]},{id:"13475323",values:["ALEMBICLTD","Alembic Limited","37.25","-0.25","chr","-0.67","","9.88B","NSE","13475323","ALEMBICLTD"]},{id:"6286747",values:["506260","Anuh Pharma Ltd","220.10","+3.00","chg","1.38","","5.55B","BOM","6286747","506260"]},{id:"8321085",values:["530317","Godavari Drugs Ltd","43.60","+1.10","chg","2.59","","328.73M","BOM","8321085","530317"]},{id:"16520755",values:["INDSWFTLTD","IND Swift Ltd.","5.80","0.00","chb","0.00","","294.64M","NSE","16520755","INDSWFTLTD"]},{id:"5262084",values:["MARKSANS","Marksans Pharma Limited","40.95","0.00","chb","0.00","","16.78B","NSE","5262084","MARKSANS"]},{id:"10147154",values:["NATCOPHARM","Natco Pharma Ltd.","583.00","-1.60","chr","-0.27","","100.89B","NSE","10147154","NATCOPHARM"]},{id:"13313409",values:["GLAXO","GlaxoSmithKline Pharmaceuticals Ltd.","2,743.45","+12.95","chg","0.47","","232.36B","NSE","13313409","GLAXO"]},{id:"3578659",values:["DRREDDY","Dr.Reddy's Laboratories Ltd","3,072.00","-11.40","chr","-0.37","","525.26B","NSE","3578659","DRREDDY"]},{id:"2456500",values:["WANBURY","Wanbury Limited","66.70","+2.90","chg","4.55","","1.35B","NSE","2456500","WANBURY"]},{id:"16546949",values:["531633","Lincoln Pharmaceuticals Ltd","188.50","-0.05","chr","-0.03","","3.80B","BOM","16546949","531633"]}],visible_cols:[0,1,4,30,34,31,32,5]},related_str:"1402851,13475323,6286747,8321085,16520755,5262084,10147154,13313409,3578659,2456500,16546949",perf:[{u:"/finance?q=NSE:APLLTD",name:"APLLTD",cp:"0.08",p:"602.00",cid:"1402851"}],t:"NSE:APLLTD: {LAST} {CHANGE} ({CHANGE_PCT}%) - Alembic Pharmaceuticals Ltd",ticker:"NSE:APLLTD",cid:"1402851"},stickyUrlArgs:"\u0026ei=WJ5rWOGGHZPYuATI5a2wAw",chart:{_5d:"EXCHANGE%3DNSE\nMARKET_OPEN_MINUTE=555\nMARKET_CLOSE_MINUTE=930\nINTERVAL=120\nCOLUMNS=DATE,CLOSE,VOLUME\nDATA=\nTIMEZONE_OFFSET=330\na1482896880,610.75,1\n1,608,27\n2,610.7,4\n3,608.35,57\n4,608.5,138\n5,605.55,193\n6,605.2,42\n7,607.2,6\n8,609.65,151\n9,606.55,106\n10,606.65,16\n11,607.95,35\n12,609.9,46\n13,609.3,9\n14,609.85,20\n15,609.85,9\n16,609.75,8\n17,612,287\n18,612.75,610\n19,611.3,143\n20,611.2,13\n22,610.1,46\n23,610.05,67\n24,610.3,66\n25,610,12\n27,610.05,6\n28,612.2,71\n29,611.05,76\n30,611.75,7\n31,611.95,6\n32,613,39\n33,613.4,297\n34,613.95,188\n35,613.25,238\n36,611.95,441\n37,611.75,105\n38,611.75,1\n39,611.8,9\n40,612,10\n41,612,3\n42,612,7\n43,613.05,2337\n44,613,27\n45,612.8,31\n46,612.75,18\n47,612.75,5\n48,612.7,38\n49,613.35,175\n50,612.9,19\n51,613,41\n52,612.9,17\n53,612.55,90\n54,613,2787\n55,612.5,807\n56,611.95,149\n57,611.95,8\n58,612.35,10\n59,611.95,6\n60,611.95,3\n61,612,262\n62,611.85,17\n63,611.8,32\n64,611.55,19\n65,611.65,38\n66,611.6,7\n67,611.6,7\n68,611.55,6\n69,611.6,11\n70,612.3,965\n71,614.9,4017\n72,614.95,2447\n73,614.85,1200\n74,614.85,565\n75,613.85,231\n76,614.4,3296\n77,616.05,2125\n78,615,1068\n79,614.85,303\n80,614.85,146\n81,614.95,1412\n82,614,260\n83,613.95,13\n84,613.9,11\n85,613.9,9\n86,613.9,10\n87,613.85,9\n88,613.85,19\n89,613.95,810\n90,613.95,140\n91,614,2535\n92,614.3,337\n93,614.25,2\n94,614.05,28\n97,613.7,9\n98,613.5,23\n99,613.5,21\n100,613.25,11\n101,613,497\n102,613,35\n103,613.9,980\n104,614,1082\n105,613.95,1530\n106,614,72\n107,613.95,220\n108,613.95,3\n109,613.8,369\n110,612.65,292\n111,612.65,32\n112,612.05,11\n113,612.05,6\n114,612,6\n115,611.85,31\n116,611.75,10\n117,611.75,11\n118,612,75\n119,612,118\n120,612,9\n121,612,50\n122,612,11\n123,612.05,166\n124,611.95,22\n125,611.7,28\n126,611.7,18\n127,611.65,67\n128,612,197\n129,611.95,108\n130,611.95,35\n131,611.95,251\n132,611.95,2\n133,611.9,15\n134,611.85,8\n135,611,96\n136,610.05,674\n137,610,132\n138,610.3,148\n139,610.4,18\n140,610.3,87\n141,611.7,242\n142,611.5,25\n143,612.05,323\n144,612.05,84\n145,611.75,306\n146,611.75,36\n147,611.45,59\n148,611,74\n149,610.55,31\n150,610.95,201\n151,610.45,419\n152,610,82\n153,609.95,54\n154,610,345\n155,610,84\n156,610,55\n157,610,49\n158,610,75\n159,609,133\n160,609.15,2567\n161,609.15,88\n162,609.2,32\n163,609.2,627\n164,609,59\n165,609.2,406\n166,609,2179\n167,609,589\n168,609,796\n169,609,280\n170,609,302\n171,609.05,278\n172,609.45,265\n173,610.1,511\n174,609.9,372\n175,609.7,411\n176,609,164\n177,609.6,178\n178,609.6,50\n179,609.65,56\n180,609.65,96\n181,609.5,155\n182,609.65,143\n183,610,1283\n184,610,288\n185,610.8,1869\n186,612,124\n720,610.35,2\n721,611.95,68\n722,612.4,20\n723,612.3,1\n724,613.4,5\n725,612.6,20\n727,611.7,58\n728,611.7,5\n729,612.4,52\n730,612.05,134\n733,612,26\n734,609.05,126\n735,608.35,28\n736,608.05,1\n737,608.45,25\n738,609.8,126\n740,610,282\n741,609.6,96\n742,610,62\n743,610,33\n744,610,21\n746,609.6,79\n747,609.6,451\n748,609.45,48\n749,609.45,32\n750,609.2,9\n751,609.1,7\n752,609.2,60\n753,609.15,65\n754,609.1,7\n755,608.95,1\n756,608.95,10\n757,609,25\n758,608.7,12\n760,609,11\n761,609.5,25\n762,609.5,16\n763,609.05,28\n764,608.95,5\n765,608.75,51\n766,607,192\n767,607.05,20\n768,607,11\n771,608,65\n772,607,13\n773,606.5,67\n774,605.9,51\n775,607,10054\n777,607,30\n780,607,91\n781,609.4,26\n782,609.55,204\n783,609.45,5\n785,609.45,48\n790,609.45,5\n793,609,38\n794,607.35,12\n795,607.35,28\n797,607.4,44\n802,608.4,8\n803,608.9,7\n805,608.9,27\n806,609,50\n807,608,250\n811,608.9,5\n812,609.25,6\n814,608.25,9\n815,608,50\n820,607.55,239\n821,607.4,105\n822,607.4,5\n823,607.45,25\n824,604,551\n825,604,394\n826,603.5,327\n827,604,166\n828,603.95,107\n829,605.4,25\n830,603.75,51\n831,607.2,64\n833,607.15,3\n834,606.05,18\n836,604,654\n837,604,125\n838,603.55,21\n839,604,108\n840,604,89\n841,606.1,112\n843,606.1,7\n844,604.2,40\n845,606.05,2\n847,606.05,5\n849,607.55,319\n850,606.55,10\n851,606.55,10\n852,606.6,10\n855,606,10\n856,606,1\n858,606,243\n859,606.4,837\n860,606,51\n861,605.05,144\n863,605.7,20\n864,605.1,14\n866,605.8,30\n868,605,141\n869,605.7,54\n871,605.7,9\n872,605.6,307\n873,605.75,3\n874,605.85,8\n875,605.85,7\n876,605.75,207\n877,606,37\n878,605.7,181\n879,604.7,464\n880,605,843\n881,604.65,536\n882,603,1566\n883,603.9,7\n884,604,1794\n885,604,86\n886,604,147\n887,603.75,14\n888,603.2,137\n889,602.55,317\n890,603.95,134\n891,604.95,499\n892,605,270\n893,604.35,141\n894,604,90\n895,604.3,418\n896,603.5,144\n897,603,86\n898,601,9604\n899,601.8,403\n900,601.8,595\n901,602.15,58\n902,603,113\n903,603.05,64\n904,603.05,294\n905,603.5,705\n906,606.3,384\na1483069560,604.1,14\n1,606.7,1\n2,607,65\n3,607.9,44\n5,609.05,54\n6,610.85,353\n7,612.5,753\n8,611.65,20\n9,609.1,75\n10,609.05,70\n11,608,95\n12,608.9,6\n13,610,100\n14,609.6,40\n15,606.4,178\n16,606.3,169\n17,606.25,180\n18,608.05,294\n19,606.3,167\n20,605.6,214\n21,606,158\n22,605.65,241\n23,606.15,166\n24,607.25,243\n25,606,460\n26,606,275\n27,606,163\n28,605.55,172\n29,605.05,204\n30,605,732\n31,606.25,64\n32,606.65,2\n33,607,42\n36,607.05,47\n37,607,554\n38,607.45,2\n42,607,22\n43,607.35,1\n45,608,59\n46,611.35,518\n47,607.7,331\n48,605.9,87\n49,605.4,16\n50,604.1,119\n51,604.75,30\n52,605,124\n53,605.45,41\n54,605.2,32\n55,605.05,41\n56,605.4,17\n57,604.65,167\n58,604.65,136\n59,605.45,102\n60,605.35,16\n61,605.35,6\n63,605.75,4\n64,605.3,543\n65,605,586\n66,605,146\n68,604.65,2\n70,605,207\n73,605,12\n74,605,224\n75,605,48\n76,605,2\n77,605,100\n79,605,228\n80,605,379\n81,604.55,110\n83,604.7,63\n84,604.6,8\n85,605,100\n86,604.35,31\n87,604.9,245\n90,603.5,200\n93,604.6,4\n95,604.8,52\n96,604.9,24\n97,604.9,50\n98,604.65,1\n100,604.9,6\n102,604.9,191\n103,604.95,8\n105,605,100\n106,605,165\n108,604.7,280\n109,605,25\n111,604,75\n113,603.3,80\n114,604.35,24\n119,604.3,6\n120,604.3,2\n122,604,84\n125,603.9,46\n126,604.3,10\n128,605,387\n129,604.75,134\n130,604,161\n131,604,57\n132,604,97\n133,604,103\n134,604,65\n135,604,88\n136,604,226\n137,604,62\n138,603.95,148\n139,604,58\n140,603.9,818\n141,602,606\n142,602.3,840\n143,602,534\n144,602.15,309\n145,602.1,84\n146,602,362\n147,602.15,99\n148,601.95,72\n149,602.15,408\n150,602.05,676\n151,602,151\n152,602.1,1313\n153,601.9,359\n154,601.95,98\n155,599.5,1667\n156,598.75,277\n157,597.75,612\n158,597.95,239\n159,597.95,398\n160,599.35,1245\n161,600,1051\n162,600,1765\n163,600.4,396\n164,600.05,254\n165,599.95,256\n166,600.4,358\n167,600.15,266\n168,600,1172\n169,599.9,479\n170,599.95,273\n171,600.1,256\n172,600,629\n173,600,249\n174,600.35,376\n175,600,402\n176,600.4,277\n177,600.4,788\n178,600,232\n179,600.35,651\n180,600,241\n181,600,316\n182,596.5,2460\n183,595.05,4933\n184,590.05,3677\n185,593.45,2369\n186,591.95,606\n187,593.95,1065\na1483328760,601.2,42\n1,604,102\n2,605.65,653\n3,602.8,1\n4,604.9,6\n5,604.9,25\n6,603.9,4\n7,604,2\n8,603.05,3\n9,603.15,32\n10,602.95,56\n11,602.05,50\n12,601.7,45\n13,601.7,14\n14,602.5,127\n15,602.95,96\n16,602.95,85\n17,603.2,103\n18,600.05,562\n19,601.65,10\n21,600.3,59\n24,599.45,1\n26,599.95,202\n29,598.3,13\n30,598.95,117\n32,598.9,8\n33,597.5,81\n34,597.95,12\n35,597.95,5\n37,598,10\n39,597.95,20\n40,597.55,15\n41,597.55,145\n43,597.6,11\n44,598.1,7\n45,598.85,23\n46,599.95,67\n47,599.7,20\n49,600.85,50\n50,599.85,1\n51,600.9,15\n52,600.2,2\n53,599.75,109\n54,600.5,53\n55,600.5,3\n56,600,18\n58,599.1,115\n60,599,48\n61,600.5,39\n62,600.95,71\n64,601,112\n65,601.05,20\n66,601,52\n67,601,16\n69,601.95,26\n70,602,160\n71,602,7\n72,602,14\n73,602,5\n75,602,18\n76,602,60\n77,601.35,60\n78,601.95,2\n80,602.8,616\n81,603.85,302\n82,603.6,101\n83,602.85,286\n85,602.1,107\n86,602.15,3\n88,603.35,5\n89,603.25,50\n91,602.1,178\n92,603.4,36\n93,603.35,2\n95,603.35,19\n97,603.3,13\n100,603.3,75\n101,603,130\n102,602.65,10\n103,602.95,4\n104,602.65,7\n106,602.65,4\n109,602.1,50\n110,602.15,10\n111,602,519\n113,602,69\n115,602,350\n116,602,298\n117,602,15\n118,601,400\n121,601,8\n122,602,132\n126,601.1,3\n128,601.95,3\n129,601.95,10\n131,601.95,26\n135,601.95,10\n137,601.15,7\n138,602,144\n140,602,94\n141,602,55\n142,601.05,511\n143,601.95,302\n144,601,190\n145,601,50\n147,601.5,2\n148,601.5,12\n149,601,100\n151,601.75,43\n152,601.05,9\n157,601,50\n159,603.3,536\n160,603,188\n161,603,532\n163,602,340\n164,602,65\n165,603.5,550\n166,603.55,4\n168,602.05,212\n172,602,15\n173,601,27\n175,601,25\n176,601.75,657\n177,601.2,502\n178,602.45,310\n179,600.7,50\n181,600,560\n182,602,84\n183,604.95,1022\n184,602,260\n185,602,41\n187,600,345\n720,604.7,15\n721,604.5,30\n724,601,50\n725,600.65,20\n726,600.65,25\n727,601.7,28\n728,600.75,30\n730,601.55,169\n731,601.85,9\n732,601.85,22\n733,601.85,9\n734,600.05,71\n735,601.4,127\n736,601.7,330\n738,601.35,25\n739,601.05,66\n740,601.05,37\n744,602.25,24\n745,602.55,45\n746,602.45,88\n748,602.55,6\n749,602.45,93\n750,602.7,124\n751,603.1,36\n754,602.6,68\n755,602.5,10\n756,602.1,46\n757,602.1,14\n758,602.15,36\n759,602.15,11\n760,601.7,54\n761,601.85,39\n762,601.65,23\n763,602.85,148\n764,601.55,69\n765,601.5,167\n766,602,448\n767,602.05,70\n768,602.1,85\n769,602,91\n770,602,49\n771,602.05,142\n772,602.45,10\n773,602.35,736\n774,602,2410\n775,602,47\n776,602.5,250\n777,602,28\n778,602,1659\n780,602.5,7\n781,602,332\n782,602,13\n783,602,97\n784,602,89\n785,602,370\n786,602,43\n787,602,101\n788,602,105\n789,602,60\n790,602,158\n791,602,94\n792,602,59\n793,602,93\n794,602.05,59\n795,602,145\n796,602,36\n797,602,99\n798,602,54\n799,602,96\n800,602.05,237\n801,602,14\n802,602,27\n803,602,39\n805,602,1050\n806,602,31\n808,602,38\n809,602,16\n810,602,37\n811,602,22\n812,602,157\n813,602,2135\n814,602,39\n815,602.15,153\n816,602.1,16\n818,602.05,19\n819,602.05,24\n820,602,58\n821,602,31\n822,602.05,31\n823,602,49\n824,602,41\n825,602,50\n826,602,50\n827,602,46\n829,602.25,107\n830,602.5,31\n831,602.1,47\n832,602.6,18\n833,602.5,125\n835,602.5,2\n837,602.15,718\n838,602,591\n840,602,15\n841,602.05,39\n842,602,385\n843,602,37\n844,602,32\n845,602.1,99\n846,602.1,55\n847,602.2,28\n848,602,1039\n849,603.35,476\n850,603.35,10\n851,603.3,24\n854,602,2057\n855,602.05,43\n856,602.05,38\n857,602.05,63\n858,602.2,161\n859,602.1,37\n860,602.05,29\n861,602.15,374\n862,602.1,101\n863,602.1,30\n864,602.1,83\n865,602.05,30\n866,602.25,138\n867,602.2,4\n869,602,19\n870,602,110\n871,602.15,195\n872,601.95,262\n873,602,235\n874,602.05,805\n875,602.05,261\n876,602.05,445\n877,602.05,519\n878,602,62\n879,602,134\n880,602,330\n881,602,68\n882,602,105\n883,602,287\n884,601.7,111\n885,602.05,132\n886,602.05,187\n887,602,105\n888,602,46\n889,602.05,95\n890,602,28\n891,602.1,812\n892,602.3,160\n893,602.25,32\n894,602,82\n895,602.9,151\n896,602.25,17\n897,602.2,32\n898,602.2,74\n899,602,120\n900,602,90\n901,602.05,225\n902,602,253\n903,602.1,309\n904,602,4623\n905,602,1636\n906,602,1397\n907,602,448\n",_5Y:"EXCHANGE%3DNSE\nMARKET_OPEN_MINUTE=555\nMARKET_CLOSE_MINUTE=930\nINTERVAL=604800\nCOLUMNS=DATE,CLOSE,VOLUME,CDAYS\nDATA=\nTIMEZONE_OFFSET=330\na1325922300,36.85,58335,6\na1326448800,38,180425,6\n1,37.55,226059,5\n2,38.5,172198,4\n3,41.55,133952,5\n4,42.6,496024,5\n5,47,1025923,5\n6,46.3,387650,4\na1330760700,46.25,299908,5\na1331287200,44.75,235921,5\n1,43.5,344532,5\n2,45.85,241753,5\n3,48.9,275251,5\na1333533600,53.6,467129,5\na1334311200,56.8,354384,5\n1,57,717548,5\n2,54.5,700962,5\n3,52.25,318724,5\n4,52,406637,5\n5,49.4,244336,5\n6,49.8,209749,5\n7,48.75,84252,5\n8,49,29161,5\n9,53.7,532204,5\n10,54.8,468149,5\n11,55.5,342794,5\n12,57.45,909687,5\n13,57.3,283944,5\n14,58.15,23403,5\n15,60,901778,5\n16,64.5,612250,5\n17,58.7,1176813,5\n18,62.75,751910,4\n19,73.2,1625892,4\n20,68.6,1049524,5\na1347090300,75.5,1317196,6\na1347616800,73.1,1093448,6\n1,71.25,703622,4\n2,72,1147996,5\n3,70.3,500886,4\n4,69.9,355427,5\n5,69.95,616626,5\n6,69.1,86539,4\n7,68.1,333608,5\n8,68.25,372873,5\n9,66.35,333311,5\n10,62.05,501406,5\n11,63.45,307797,4\n12,65,402739,5\n13,68.1,468167,5\n14,67.35,384167,5\n15,69,195139,4\n16,72,813848,5\n17,71.2,553299,5\n18,71.35,427253,5\n19,70.9,1095051,5\n20,76.25,1876173,5\n21,74.05,358057,5\n22,76.8,377980,5\n23,77.3,221068,5\n24,82.5,707151,5\n25,99.2,2940215,5\n26,98.85,2073325,5\n27,104.25,1149530,5\na1364464800,103.5,409252,5\na1365156000,114.65,854360,5\n1,107.75,585631,5\na1366279200,117.1,750196,5\na1366970400,110.25,458671,5\n1,123,1708754,5\n2,122.15,646058,5\n3,131.05,1238334,5\n4,118,638971,5\n5,134,3008804,5\n6,143.5,1428849,5\n7,131.95,1325685,5\n8,133.15,1474429,5\n9,132.2,1371007,5\n10,147.2,1411123,5\n11,158.8,2319684,5\n12,164,907621,5\n13,151.25,454122,5\n14,141.5,1360032,5\na1375956000,156.3,1625546,5\na1376647200,144.7,480594,5\n1,142,633701,5\n2,133.5,482191,5\n3,135,500628,5\n4,139.6,669039,5\n5,136.8,283198,5\n6,141.45,788805,5\n7,150,390430,5\n8,175,1899291,5\n9,168,536859,5\n10,179.35,1191856,5\n11,195,2374522,5\n12,205,1358431,5\n14,199.5,498663,5\n15,204.55,522640,5\n16,205.35,630912,5\n17,193.35,390834,5\n18,211.25,1355169,5\n19,211.15,595924,5\n20,211,274012,5\n21,222.2,2022127,5\n22,219.8,992401,5\n23,222.25,2235990,5\n24,221.5,717731,5\n25,230.9,623203,5\n26,232.95,570450,5\n27,248.2,915073,5\n28,267.75,941945,5\n29,282,2061540,5\n30,276.9,2444222,5\n32,282.8,1034066,5\n33,280.55,832444,5\n34,275.35,766165,5\na1397728800,269.75,242950,5\na1398420000,306.4,1900741,5\n1,296.25,1684533,5\n2,273,557203,5\n3,257,1137890,5\n4,238.8,1890338,5\n5,246.4,656991,5\n6,241.9,922044,5\n7,271.1,1731101,5\n8,277.15,817074,5\n9,269,455065,5\n10,310,2553138,5\n11,305,1236139,5\n12,337.9,1381597,5\n13,331,1453618,5\n14,336.75,1571253,5\n15,341.75,1676087,5\na1408010400,353,809566,5\na1408701600,386,1456797,5\na1409220000,370.15,825347,5\na1409911200,395.6,1948962,5\n1,430,1071688,5\n2,421.55,1044558,5\n3,414,1024992,5\na1412157600,416,496703,5\na1412935200,388,523722,5\n1,388.05,945870,5\na1414058400,423,1120555,5\na1414749600,406,592578,5\n1,407.2,436137,5\n2,448,1530240,5\n3,437,693077,5\n4,422.5,504419,5\n5,443.4,1057417,5\n6,432.5,337830,5\n7,423.45,346337,5\n8,425.55,212805,5\n9,458,376544,5\n10,473,976409,5\n11,459.05,356425,5\n12,475,623019,5\n13,469.1,554189,4\n14,422.75,1571020,5\n15,424.15,1886177,5\n16,423.85,574459,4\na1425119400,405,1380916,6\na1425549600,431,1109952,5\na1426240800,446,951123,5\n1,450,1009715,5\n2,447.05,486740,5\na1427882400,454,286253,5\na1428660000,485,636682,5\n1,484,710398,4\n2,486,683582,5\na1430388000,471.4,1997787,5\na1431079200,470.55,656335,5\n1,497.05,880403,5\n2,540.15,1289955,5\n3,554,404925,5\n4,555.4,932765,5\n5,564.3,837604,5\n6,667,2164251,5\n7,659,1596868,5\n8,680,1250588,5\n9,757,1988349,5\n10,759.55,864295,5\n11,753,622017,5\n12,715.8,1694853,5\n13,705.2,1021003,5\n14,703.75,946796,5\n15,710,492220,5\n16,702.5,612443,5\n17,678,548906,5\n18,665,566354,5\n19,684,337354,4\na1443088800,675,402460,4\n1,705,825537,5\na1444384800,724,678380,5\n1,717,520707,5\n2,693.1,237550,4\n3,677.9,2876982,5\n4,671,638596,5\n5,663.2,217865,4\n6,659,494843,5\n7,691.95,502735,4\n8,684,404086,5\n9,661.75,296988,5\n10,678,253916,5\na1450951200,698,547024,5\na1451642400,686,577317,5\n1,667.25,290582,5\n2,619.9,566180,5\n3,630,1397575,5\n4,619.5,961645,4\n5,590,1164483,5\n6,586.05,465757,5\n7,617.9,445220,5\n8,608,232541,5\n9,640,458241,5\n10,615.05,242895,4\n11,610,258202,5\na1458727200,609,297188,5\na1459504800,592,1097991,5\n1,553.1,522021,5\na1460541600,561.3,264813,4\na1461319200,617.85,1362901,4\n1,600,2045733,5\n2,594.6,695708,5\n3,583,462025,5\n4,563,424980,5\n5,540,475531,5\n6,558,668337,5\n7,562.85,201855,5\n8,528.4,563493,5\n9,537,286337,5\n10,582.1,1036655,5\n11,598,862516,4\n12,575.6,277858,5\n13,588,236289,5\n14,627.2,1196803,5\n15,635.95,500271,5\n16,649.8,356772,5\n17,648,288167,4\n18,635,201312,5\n19,621.5,222007,5\n20,634,343122,4\n21,655,540908,4\n22,677.5,586674,5\n23,652.5,468346,5\n24,673.25,678597,5\n25,680.1,295689,3\n26,676,375790,5\n27,677,724775,5\n28,658,381269,5\n29,636.2,316834,5\n30,606,425976,4\n31,648,467788,5\n32,630.9,396528,5\n33,639,149277,5\n34,624,228748,5\n35,614.95,101171,5\n36,593.95,229382,5\n",corp_actions:"[{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1313466300\",\"_amount\":\"1.0\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1314675900\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1343706300\",\"_amount\":\"1.4\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1344570300\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1375069500\",\"_amount\":\"2.5\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1376451900\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1405568700\",\"_amount\":\"3\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1406605500\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1437536700\",\"_amount\":\"3.5\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1438919100\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1468986300\",\"_amount\":\"4\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1470368700\"}]",related_items:[{ticker:"NSE:ALEMBICLTD",name:"ALEMBICLTD",timezone_offset:19800,is_index:false},{ticker:"BOM:506260",name:"506260",timezone_offset:19800,is_index:false},{ticker:"BOM:530317",name:"530317",timezone_offset:19800,is_index:false},{ticker:"NSE:INDSWFTLTD",name:"INDSWFTLTD",timezone_offset:19800,is_index:false},{ticker:"NSE:MARKSANS",name:"MARKSANS",timezone_offset:19800,is_index:false},{ticker:"NSE:NATCOPHARM",name:"NATCOPHARM",timezone_offset:19800,is_index:false},{ticker:"NSE:GLAXO",name:"GLAXO",timezone_offset:19800,is_index:false},{ticker:"NSE:DRREDDY",name:"DRREDDY",timezone_offset:19800,is_index:false},{ticker:"NSE:WANBURY",name:"WANBURY",timezone_offset:19800,is_index:false}]}};
google.finance.data.numberFormat = [{'threshold':1000000, 'symbol':'M'}, {'threshold':1000000000,'symbol':'B'}, {'threshold':1000000000000,'symbol':'T'}] ;
_setStickyUrlParams("ei=WJ5rWOGGHZPYuATI5a2wAw");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
google.finance.renderRecentQuotes();
', 
', 
', 
', 
', 
', 
', 
', 
', google.finance.renderRelativePerformance();', 
', 
', 
', 
', 
', 
', 
', 
', 602.00', 
', 
', 
', +0.50', 
', (0.08%)', 
', 
', 
', 
', 
', 
Jan 3 - Close
', 
', 
', NSE
real-time data -
', Disclaimer', 
', 
', Currency in INR', 
', 
', 
', 
', 
', 
', 
', 
', Range
', 
', 600.05 - 605.05
', 
', 
', 
', 52 week
', 
', 512.50 - 699.00
', 
', 
', 
', Open
', 
', 602.35
', 
', 
', 
', Vol.
', 
', 36,777.00
', 
', 
', 
', Mkt cap
', 
', 113.71B
', 
', 
', 
', P/E
', 
', 19.46
', 
', 
', 
', Div/yield
', 
', 4.00/0.66
', 
', 
', 
', EPS
', 
', 30.94
', 
', 
', 
', Shares
', 
', 188.52M
', 
', 
', 
', Beta
', 
',     -
', 
', 
', 
', Inst. own
', 
',     -
', 
', 
', 
', 
', 
', 
', 
', 
', google.finance.renderMarketData();', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', News', 
', 
', 
', 
', 
', 
', Relevance', 
', 
', 
', 
', Date', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', All news for Alembic Pharmaceuticals Ltd »', 
', 
', Subscribe', 
', 
', 
', 
', 
', 
', 
', Advertisement', 
', 
', 
', Key stats and ratios', 
', 
', 
', 
', 
', u"Q3 (Sep '16)
", 2016
', 
', 
', Net profit margin
', 14.05%
', 22.74%
', 
', Operating margin
', 17.87%
', 29.52%
', 
', EBITD margin
', -
', 31.80%
', 
', Return on average assets
', -
', 35.38%
', 
', Return on average equity
', -
', 58.01%
', 
', Employees
', 8,007
', -
', 
', CDP Score
', -
', 
-
', 
', 
', 
More ratios from Thomson Reuters »', 
', 
', Address', 
', Alembic Road', VADODARA, 390003', India', +91-265-2282550 (Phone)', +91-265-2281508 (Fax)', 
', 
', Website links', 
', 
', 
http://www.alembic-india.com/
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Settings',  |
', Technicals',  |
', 
', 
', 
Link to this view', 
', 
', 
', 
', Sources include SIX.', 
', 
', 
', 
', 
', 
var _minZoomDays = 1;
var _minZoomDaysNoIntraDay = _minZoomDays;
var _timeZoneOffset = '19800';
_chartConfigObject = {};
_chartConfigObject.hasVolume = _displayVolume;
_chartConfigObject.hasNews = true;
_chartConfigObject.hasExtendedHours = false;
_chartConfigObject.hasDefaultZoomSetting = true;
_chartConfigObject.hasVerticalScaleSetting = true;
_chartConfigObject.displayVolume = 'true';
_chartConfigObject.displayNewsPins = 'true';
_chartConfigObject.displayDividends = 'true';
_chartConfigObject.displaySplits = 'true';
_chartConfigObject.displayExtendedHours = 'false';
_chartConfigObject.enableCustomDateEntry = true
_chartConfigObject.defaultZoomDays = '3';
_chartConfigObject.snapping = false;
_chartConfigObject.verticalScaling = 'maximized';
_chartConfigObject.sparklineType = 'dynamic';
// set _minZoomDays and _minZoomDaysNoIntraDay in each page before emit the
// chart to passing the value to chart, otherwise default value will be use.
_chartConfigObject.minZoomDaysNormal = _minZoomDays;
_chartConfigObject.minZoomDaysNoIntraDay = _minZoomDaysNoIntraDay;
_chartConfigObject.enableIndicator = true;
_chartConfigObject.companyId = '1402851';
_chartConfigObject.enableRealtimeChart = true;
_chartConfigObject.isMarketOpenState = 0;
_chartConfigObject.stateRemainingMinutes = 894;
_chartConfigObject.delayedMinutes = 0;
_chartConfigObject.enableChartTypeSetting = true;
_chartConfigObject.lineStyle = 'IntervalBasedLine';
_chartConfigObject.defaultInterval = '86400';
_chartConfigObject.enableIndicatorSetting = true;
_chartConfigObject.biasSetting = '';
_chartConfigObject.emaSetting = '';
_chartConfigObject.kdjSetting = '';
_chartConfigObject.macdSetting = '';
_chartConfigObject.rsiSetting = '';
_chartConfigObject.smaSetting = '';
_chartConfigObject.vmaSetting = '';
_chartConfigObject.cciSetting = '';
_chartConfigObject.williamsPercentRSetting = '';
_chartConfigObject.bollingerBandsSetting = '';
_chartConfigObject.fastStochasticSetting = '';
_chartConfigObject.slowStochasticSetting = '';
_chartConfigObject.expandButtonEnabled = true;
_chartConfigObject.companyCurrency = 'INR';
_chartConfigObject.displayDividendsUnits = 'false';
_external_target = "";
_emitFlashChart(
"/finance/s/n-VxNKK74DU/chart9.swf?hl=en&gl=us",
_ticker, _chartConfigObject,"http:\x2F\x2Fwww.google.com:80");
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Advertisement', 
', 
', 
', 
', 
', 
', 
', 
', Related companies', 
', 
', 
', 
', 
', 
Show:
', 
', 
Most Recent Quarter
', 
', 
Most Recent Annual
', 
', 
', 
', 
', Add or remove columns', 
', Save changes', 
', Cancel', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', More from FactSet »', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Description', 
', 
', 
', 
', 
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.
', 
', 
More from Reuters »
', 
', 
', 
', 
', u"_tck('aft');", 
', 
', 
', 
', Officers and directors', 
', 
', 
', 
', 
', 
', Chirayu R. Amin
', 
', Executive Chairman of the Board, Chief Executive Officer
', 
', 
', 
', 
', 
Age: 66', 
', 
', Rajkumar K. Baheti
', 
', Chief Financial Officer, Director - Finance, Executive Director
', 
', 
', 
', 
', 
Age: 54', 
', 
', Ajay Kumar Desai
', 
', Associate Vice President-Finance, Company Secretary and Compliance Officer
', 
', 
', 
', 
', 
', 
', Pranav Amin
', 
', Managing Director, Executive Director
', 
', 
', 
', 
', 
Age: 38', 
', 
', Shaunak Amin
', 
', Managing Director, Director
', 
', 
', 
', 
', 
', 
', Archana Hingorani
', 
', Additional Independent Director
', 
', 
', 
', 
', 
', 
', Milin Mehta
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', Pranav N. Parikh
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', K. S. Ramanathan
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', Paresh Saraiya
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', 
', 
Full list on Reuters »', 
', 
', 
', 
', 
', 
', 
', 
', 
', Google Finance Beta available in: ', Hong Kong',  - ', Canada',  - ', U.S.',  - ', China',  - ', U.K.', Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.', To see all exchange delays, please ',  see disclaimer', .', ©2017 Google - ', Google Home',  - ', Blog',  - ', Help',  - ', Report a Problem',  - ', Privacy Policy',  - ', Terms of Service', 
', 
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = 'WJ5rWOGGHZPYuATI5a2wAw';
var _expid;
var _external_target;
var _localDomain = 'www.google.com';
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
_setStickyUrlParams("ei=WJ5rWOGGHZPYuATI5a2wAw");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
_regOnLoad(onCompanyLoad);
', 
', var googlefinance = {i: ["f.b.id","",null,0,"",0,null,["f.b.cf","9R147Dhnn8c.en_US.",0],[],1,[],"WJ5rWOGGHZPYuATI5a2wAw","www.google.com","lgHEJDE7I6CVLCxcM9-waHHCc5w:1483447896814",1]}; GF_domReady = 1;'][Search',  ', Images',  ', Maps',  ', Play',  ', YouTube',  ', News',  ', Gmail',  ', Drive',  ', More',  »', Help',  | ', Sign in', u"
(function() {
  var l = window.location;
  var q = l.search ? l.search.substr(1) : '';
  var h = l.hash ? l.hash.substr(1) : '';
  var p = '/finance';
  var ss = 'stockscreener';
  var conn = window.history && window.history.pushState ? '/' : '#';
  if (l.pathname == p + '/' + ss) {
    if (h) l.href = p + conn + ss + '?' + q + '&' + h;
  } else if (l.pathname != p && h) {
    l.href = p + l.hash;
  }
  if (h) {
document.getElementById('fjfe-click-wrapper').style.display = 'none';
  }
})();
", Company', Summary', News', Related companies', Historical prices', Markets', News', Portfolios', Stock screener', Google Domestic Trends', Recent Quotes ', (', 30 days', )', You have no recent quotes', chg',  | ', %', APLLTD', 602.00', +0.500', 0.08%', u"var _cleardot = 'data:image\/gif;base64,R0lGODlhAQABAIAAAP\/\/\/\/\/\/\/yH5BAEKAAEALAAAAAABAAEAAAICTAEAOw\x3d\x3d';
    var google = google || {};
    google.finance = google.finance || {};
    google.finance.gce = false ;", u"
      _regOnLoad = function(f) {
        if (document.readyState == 'complete') {
          f && f();
        } else {
          // Window.attachEvent() for IE8 and below compatability.
          var addEventFunction = window.attachEvent ||
              window.addEventListener || function(ignored, f) { f(); };
          var event = window.attachEvent ? 'onload' : 'load';
          f && addEventFunction(event, f);
        }
      };
    
      google.finance.renderRecentQuotes = function() {};
    ", 
', 
(function() {
if (window['_finance_chart']) {
var el = document.getElementById('chart_anchor');
if (el) {
el.innerHTML = '';
}
setFinanceChart(null);
}
})();
var _ticker = 'NSE:APLLTD';
var _slHeight = 221;
var _companyName = 'Alembic Pharmaceuticals Ltd';
var _companyPageNewsTab = '0';
var _displayVolume = true;
setCompanyId(1402851);
_s_Store._numToDisplay = 6;
_comparison_charts_Store._numToDisplay = 8;
_comparison_charts_Store._allowMultiTimezoneCompare = true;
function onCompanyLoad() {
_external_target = "";
_emitFlashChartOnLoad(
"/finance/s/n-VxNKK74DU/chart9.swf?hl=en&gl=us",
_ticker, "chart_anchor", "market-data-div",
_chartConfigObject);
google.finance.onCompanyLoad();
_initAutoFocus();
if (google.finance.initTechnicals) {
google.finance.initTechnicals(true);
}
}
', 
', 
', 
', 
', Alembic Pharmaceuticals Ltd  ', (Public, NSE:APLLTD)  
', Watch this stock', 
 
', 
', 
', 
', 

', 
_ac_register(function (input, event) {
if (input.id == 'add_comparison_symbol') {
_comparison_charts_Store.baseTicker = "NSE:APLLTD";
return _comparison_charts_Store;
}
});
var _prefs=_prefs||{};_prefs.hash="";
_prefs.feeds=_prefs.feeds||{};
_prefs.ch=_prefs.ch||{};
_prefs.ch_compare=_prefs.ch_compare||{};
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = 'WZ5rWOHIB5PLuATpk5GoAw';
var _expid;
var _external_target;
var _localDomain = 'www.google.com';
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
var google = google || {};
google.finance = google.finance || {};
google.finance.data = {common:{rq:{ct:""},up:"chg",down:"chr",linktargetInternal:"",hash:"",dfp:"ad-g.doubleclick.net/adi/com.gf.company/default;fe=nse;ft=aplltd;fm=large;dcopt=ist;myd=ad;sz=300x250;tile=1",streaming:[{cid:"1402851",s:"APLLTD",e:"NSE"},{cid:"13475323",s:"ALEMBICLTD",e:"NSE"},{cid:"6286747",s:"506260",e:"BOM"},{cid:"8321085",s:"530317",e:"BOM"},{cid:"16520755",s:"INDSWFTLTD",e:"NSE"},{cid:"5262084",s:"MARKSANS",e:"NSE"},{cid:"10147154",s:"NATCOPHARM",e:"NSE"},{cid:"13313409",s:"GLAXO",e:"NSE"},{cid:"3578659",s:"DRREDDY",e:"NSE"},{cid:"2456500",s:"WANBURY",e:"NSE"},{cid:"16546949",s:"531633",e:"BOM"}],dfp_companion:"ad-g.doubleclick.net/adi/com.gf.company/default;fe=nse;ft=aplltd;fm=large;dcopt=ist;myd=ad2;sz=33x33;tile=2"},company:{news:{clusters:[{nrel:1,idx:0,id:"52779294660048",lead_story_url:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html",a:[{t:"Alembic Pharmaceuticals Ltd drops 1.23%",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets.",d:"Dec 5, 2016",tt:"1480941346",usg:"AFQjCNFQUS6QsEDuCFDPJSkYyd673AIw2Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-ltd-drops-1-23-116120500223_1.html\u0026cid=52779294660048\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGaK5XFGRssXGjUcC31SUu5nwFGLg"}],lead_story_doc_id:"18009592219006405310"},{idx:1,id:"0",lead_story_url:"http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals",a:[{t:"Alembic Pharmaceuticals",u:"http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals",s:"Pharmacy Times",sp:"Alembic Pharmaceuticals, Inc., is a subsidiary of Alembic Pharmaceuticals, Ltd., the oldest pharmaceutical company in India.",d:"Aug 25, 2016",tt:"1472156100",usg:"AFQjCNEiGxi_dGt-HphEg0uWlGS50Q599g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.pharmacytimes.com/publications/supplement/2016/generic-supplement-2016/alembic-pharmaceuticals\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNG0o9bUaqFTTJLgtxX9EySPkmwFlw"}],lead_story_doc_id:"15168226560533480914"},{nrel:92,idx:2,id:"52779169893848",lead_story_url:"http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html",a:[{t:"We are planning 6-8 new launches this fiscal yr: Alembic Pharma",u:"http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html",s:"Moneycontrol.com",sp:"Speaking to CNBC-TV18 Pranav Amin, Managing Director of Alembic Pharmaceuticals, said that good Q1 numbers were led by international business.",d:"Jul 29, 2016",tt:"1469783132",usg:"AFQjCNFBfxeyfat9dZJhp0UFYl2JlsVM1Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/results-boardroom/weplanning-6-8-new-launches-this-fiscal-yr-alembic-pharma_7146261.html\u0026cid=52779169893848\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFHMEkCV9yTvWGDiVS5tUBYAb6E2Q"},{t:"Alembic Pharma Q1 net jumps 45%",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-q1-net-jumps-45/article8916824.ece",s:"Hindu Business Line",sp:"Vadodara-based Alembic Pharmaceuticals Ltd has posted a net profit of Rs. 102 crore for the first quarter ended June 30, 2016, showing 45 per cent rise over Rs.",d:"Jul 29, 2016",tt:"1469783475",usg:"AFQjCNGFlHnSxVjNozaiaJvW_OezjqzVKQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-q1-net-jumps-45/article8916824.ece\u0026cid=52779169893848\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEDznjUFLsYThkV54-kzILCj-4GtA"}],lead_story_doc_id:"9928500749914579245"},{nrel:22,idx:3,id:"52779036893604",lead_story_url:"http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html",a:[{t:"Alembic Pharma Q3 profit jumps 281% to Rs 270 cr on US exports",u:"http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html",s:"Moneycontrol.com",sp:"Alembic Pharmaceuticals has reported solid earnings performance during October-December quarter with consolidated profit rising massive 281.2 percent year-on-year to Rs 269.5 crore on US business.",d:"Jan 21, 2016",tt:"1453370248",usg:"AFQjCNFgE5LYKZ0vH5IvABiBX3c776f4Aw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/results/alembic-pharma-q3-profit-jumps-281-to-rs-270-crus-exports_5104301.html\u0026cid=52779036893604\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEoeHzLMyJN7dmDvPsTnBvrx7dFdw"},{t:"Alembic Pharma gains on strong Q3 results",u:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-strong-q3-results-116012100538_1.html",s:"Business Standard",sp:"Alembic Pharmaceuticals has surged 7% to Rs 631 on the BSE after the company reported nearly four-fold jump in consolidated net profit at Rs 269 crore for the quarter ended December 2015 (Q3FY16) on back of strong growth in international business.",d:"Jan 21, 2016",tt:"1453367848",usg:"AFQjCNHQ5t3JVS7wQQQxVJE-K9HyYQX-9g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-gains-on-strong-q3-results-116012100538_1.html\u0026cid=52779036893604\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH_IpLwT71_PxKMEg4AfuBWY37VtQ"}],lead_story_doc_id:"11300447456109101484"},{nrel:2,idx:4,id:"52779275598593",lead_story_url:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece",a:[{t:"Alembic Pharma gets USFDA approval for anti-hypertension drug",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece",s:"Hindu Business Line",sp:"Vadodara-based drug player Alembic Pharmaceuticals Ltd has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Telmisartan and Amlodipine Tablets.",d:"Nov 19, 2016",tt:"1479552075",usg:"AFQjCNGp90G_sQKCEgKZy5Vl_YJFQnEcLQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-approval-for-antihypertension-drug/article9365330.ece\u0026cid=52779275598593\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGQB3YwExVl__J2jgn-e9XmLpzJUA"}],lead_story_doc_id:"14767591891315490170"},{nrel:2,idx:5,id:"52779100506485",lead_story_url:"http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/",a:[{t:"Panama Papers: Amins of Alembic set up BVI firm to buy and rent London property",u:"http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/",s:"The Indian Express",sp:"Alembic Pharmaceuticals Ltd promoter Chirayu Amin and his family members - Malika Amin, Pranav Amin, Shaunak Amin and Udit Amin - are listed as beneficiaries of Whitefield Global Investments Ltd, which was incorporated in the British Virgin Islands\u0026nbsp;...",d:"May 5, 2016",tt:"1462491455",usg:"AFQjCNEjAEY00QTE3w5y5yIrgkQQ9_kfRQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://indianexpress.com/article/india/india-news-india/panama-papers-chirayu-amin-of-alembic-bvi-firm-mossack-fonseca-2786751/\u0026cid=52779100506485\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFN_P1iNgyLWcmRXIdUc1056T4j-Q"},{t:"Alembic Pharma\u0026#39;s Chirayu Amin, family set up offshore firm in 2015, Panama ...",u:"http://www.dnaindia.com/money/report-alembic-pharma-s-chirayu-amin-family-set-up-offshore-firm-in-2015-panama-papers-reveal-2209728",s:"Daily News \u0026 Analysis",sp:"Vadodara-based Alembic Pharmaceuticals\u0026#39; promoter Chirayu Amin set up an offshore entity in the British Virgin Islands (BVI) in 2015, a report in The Indian Express has said.",d:"May 6, 2016",tt:"1462512147",usg:"AFQjCNEXFy74upbdKD60G4tZYdJmu-vE_A",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.dnaindia.com/money/report-alembic-pharma-s-chirayu-amin-family-set-up-offshore-firm-in-2015-panama-papers-reveal-2209728\u0026cid=52779100506485\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHfJGw4h4qvvWGNrXw3Br-aLBRhlg"}],lead_story_doc_id:"13257896125845329274"},{nrel:16,idx:6,id:"52779091595714",lead_story_url:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html",a:[{t:"Alembic Pharma gains on JV with Orbicular",u:"http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html",s:"Business Standard",sp:"&#8220;APL has entered into joint venture agreement dated 20th April, 2016 with Orbicular Pharmaceutical Technologies Private Limited (Orbicular) and Dr M S Mohan to develop, manufacture and commercialize dermatology products for global markets,&#8221; APL said\u0026nbsp;...",d:"Apr 21, 2016",tt:"1461219247",usg:"AFQjCNEITmY254QSQ0MALwgoP5LTmTid1A",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-gains-on-jv-with-orbicular-116042100304_1.html\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH5yM1BzFm3HfRWsI2YtYYAy__52A"},{t:"Alembic to float joint venture with Orbicular Pharma",u:"http://www.thehindubusinessline.com/companies/alembicorbicular-pharma-venture-to-develop-make-dermatology-products/article8503551.ece",s:"Hindu Business Line",sp:"Alembic Pharmaceuticals Ltd today said it has entered into a joint venture with Orbicular Pharmaceutical Technologies and Dr MS Mohan to develop, manufacture and commercialise dermatology products for global markets.",d:"Apr 21, 2016",tt:"1461219075",usg:"AFQjCNFzLGEBZVPiXQdY4DzAhPlaqQkgrA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembicorbicular-pharma-venture-to-develop-make-dermatology-products/article8503551.ece\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGUMsGfIK6BhSJvNkc5BxhwRVnPVQ"},{t:"Alembic Pharma forms JV with Orbicular",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-forms-jv-with-orbicular-116042100312_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals. Alembic Pharma has announced that it has formed 60:40 JV with Orbicular to develop \u0026amp; commercialise Derma products.",d:"Apr 21, 2016",tt:"1461215700",usg:"AFQjCNEpeL2JTuXhgp2Ke-Wf7lPKwnSGpg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharma-forms-jv-with-orbicular-116042100312_1.html\u0026cid=52779091595714\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGDzRvgOXv3ONhQBtLrppTHUgLu6Q"}],lead_story_doc_id:"5602090657821206911"},{idx:7,id:"0",lead_story_url:"http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece",a:[{t:"Alembic Pharma: Right prescription",u:"http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece",s:"Hindu Business Line",sp:"Alembic Pharmaceuticals, which was spun off following the demerger of the pharmaceuticals business from Alembic Limited in April 2010, has been doing quite well, especially in its key US market which contributes nearly half of its revenues. First, the ...",d:"Aug 20, 2016",tt:"1471708575",usg:"AFQjCNGTNViejGLMuvARteOkWW6ad0P6Kw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/portfolio/firm-calls/alembic-pharma-right-prescription/article9012263.ece\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNH1IUtc323kicln5v22Q39eWPf79A"}],lead_story_doc_id:"464119262658413092"},{nrel:8,idx:8,id:"52779096444421",lead_story_url:"http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html",a:[{t:"Alembic Pharma net profit up 30%",u:"http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html",s:"Livemint",sp:"Hyderabad: Alembic Pharmaceuticals Ltd on Wednesday said its net profit rose 30% in the quarter ended March on the back of a strong performance by its international formulations and active ingredients businesses.",d:"Apr 27, 2016",tt:"1461765150",usg:"AFQjCNGngmKzEOjXJr0iVNWKVzoA0NGWHg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.livemint.com/Companies/RYkiFYR53MQxBa5JdSFSuN/Alembic-Pharma-net-profit-up-30.html\u0026cid=52779096444421\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF1YAnNxKhfyCcEeAaQYJgCVx4g2g"},{t:"Alembic Pharma posts net profit of Rs 719 crores for quarter ending March 31, 2016",u:"http://www.financialexpress.com/article/pharma/latest-updates/alembic-pharmaceuticals-posts-net-profit-of-rs-719-crores-for-quarter-ending-march-31-2016/244444/",s:"Financial Express",sp:"Pranav Amin, Managing Director, Alembic Pharmaceuticals, &#8220;This has been an outstanding year for the company. R\u0026amp;D will continue to remain a thrust area and we hope to strengthen our portfolio rapidly in the years to come.",d:"Apr 28, 2016",tt:"1461825225",usg:"AFQjCNGzkDTYtBXidLuK32xFTTQG10OMww",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.financialexpress.com/article/pharma/latest-updates/alembic-pharmaceuticals-posts-net-profit-of-rs-719-crores-for-quarter-ending-march-31-2016/244444/\u0026cid=52779096444421\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHqlD6TwdmfMv-D9L3wE3A9k8hK_w"}],lead_story_doc_id:"5093585876226575353"},{nrel:6,idx:9,id:"52779233152487",lead_story_url:"http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms",a:[{t:"Alembic Pharma receives EIR report from USFDA",u:"http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms",s:"Economic Times",sp:"\u0026quot;The company\u0026#39;s formulation facility located at Panelav has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (FDA) for the inspection carried out by them in March 2016,\u0026quot; Alembic Pharmaceuticals said in a BSE filing.",d:"Oct 5, 2016",tt:"1475659771",usg:"AFQjCNGXO1OBg1qQDNal9fQvEMyFYRKkFg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-eir-report-from-usfda/articleshow/54694391.cms\u0026cid=52779233152487\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGgcNAEakool99L4Qaas1SHo4Sa9w"}],lead_story_doc_id:"10095635002404126976"},{nrel:17,idx:10,id:"52779098838518",lead_story_url:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece",a:[{t:"Alembic Pharma gets USFDA nod for lacosamide tablets",u:"http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece",s:"Hindu Business Line",sp:"Vadodara-based drug maker Alembic Pharmaceuticals Ltd has informed that the company has received final approval from the US drug regulator - US Food and Drug Administration (USFDA) for its Lacosamide tablets, which is indicated as adjunctive therapy\u0026nbsp;...",d:"May 2, 2016",tt:"1462183650",usg:"AFQjCNF2ZjBBOqOZl_TZVxyd8-FtVELLog",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-lacosamide-tablets/article8547105.ece\u0026cid=52779098838518\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNE-L4lIPuNej7L91VG5iAaEpAbJsQ"},{t:"Alembic Pharmaceuticals gets USFDA approval for Lacosamide Tablets",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-gets-usfda-approval-for-lacosamide-tablets-116050200095_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals has received final approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide Tablets, SO mg, 100 mg, lSO mg and 200 mg.",d:"May 2, 2016",tt:"1462170639",usg:"AFQjCNF7MXxe30c9BtQkxQDsMdjYWruvTQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharmaceuticals-gets-usfda-approval-for-lacosamide-tablets-116050200095_1.html\u0026cid=52779098838518\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHQE-xgjRvDSTJsWObtys612Y4PKw"}],lead_story_doc_id:"17622716464232799505"},{nrel:3,idx:11,id:"52779275114613",lead_story_url:"http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html",a:[{t:"Alembic Pharmaceuticals gets USFDA Approval for Telmisartan and Amlodipine Tablets",u:"http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited today announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Telmisartan and Amlodipine Tablets, 40 mg/5 mg, 40 mg/10\u0026nbsp;...",d:"Nov 18, 2016",tt:"1479468375",usg:"AFQjCNFcR4VqxtgI0uR-7DWJNjbTO3A7Eg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-chai-time/alembic-pharmaceuticals-gets-usfda-approval-for-telmisartan-and-amlodipine-tablets-116111800417_1.html\u0026cid=52779275114613\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHocicZRGTFX2pCS4uO4LrIzCZXvQ"},{t:"Alembic Pharmaceuticals receives FDA approval for hypertension tablets",u:"https://rtn.asia/d-n/25021/alembic-pharmaceuticals-receives-fda-approval-hypertension-tablets",s:"Real Time News, India",sp:"Alembic Pharmaceuticals Ltd said it received approval from the United States Food \u0026amp; Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.",d:"Nov 18, 2016",tt:"1479469498",usg:"AFQjCNEXJrj0LEG20KBB9ISDNIUBqyVXrw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=https://rtn.asia/d-n/25021/alembic-pharmaceuticals-receives-fda-approval-hypertension-tablets\u0026cid=52779275114613\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGy-WXRVw_oHt5g7hCuA9-iRPoCPw"}],lead_story_doc_id:"4767819221078404609"},{nrel:6,idx:12,id:"52779260096544",lead_story_url:"http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html",a:[{t:"Hold Alembic Pharmaceuticals; target of Rs 700: Axis Direct",u:"http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html",s:"Moneycontrol.com",sp:"Alembic is in a sweet spot given ramp-up on small US revenue base, lower USFDA risks (as facilities recently cleared by USFDA), steady India business and strong return ratios.",d:"Nov 1, 2016",tt:"1478001439",usg:"AFQjCNHpchGt31DnO_JTeHjOSRmI5mQq-g",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/recommendations/hold-alembic-pharmaceuticals-targetrs-700-axis-direct_7865821.html\u0026cid=52779260096544\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGTV3t7Ym7f1O_UY57eQnkwxs3lHg"}],lead_story_doc_id:"311637444421722264"},{nrel:4,idx:13,id:"52779308059670",lead_story_url:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html",a:[{t:"Alembic Pharma gets USFDA approval for ltraconazole Capsules; Stock jumps 0.7%",u:"http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ltraconazole Capsules, 100 mg.",d:"Dec 16, 2016",tt:"1481868675",usg:"AFQjCNEt5iuauIN0AN4Ycm8MWes5R3G3Ng",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-story/alembic-pharma-gets-usfda-approval-for-ltraconazole-capsules-stock-jumps-0-7-116121600246_1.html\u0026cid=52779308059670\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEh8YvkH6Jrn7quhe6Zjvd5WlFgug"},{t:"Alembic receives USFDA approval for Itraconazole capsules",u:"http://www.moneycontrol.com/news/business/alembic-receives-usfda-approval-for-itraconazole-capsules_8126981.html",s:"Moneycontrol.com",sp:"Alembic receives USFDA approval for Itraconazole capsules. Alembic Pharmaceuticals Ltd today announced that the company has received approval from US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for\u0026nbsp;...",d:"Dec 16, 2016",tt:"1481889295",usg:"AFQjCNGA-m5giPTTzKMhWLHe7vsfhiDPGg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/business/alembic-receives-usfda-approval-for-itraconazole-capsules_8126981.html\u0026cid=52779308059670\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGvFSRARA-zJWZrgch0Ck7YDDe_Hw"}],lead_story_doc_id:"2746521445400611360"},{idx:14,id:"0",lead_story_url:"http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html",a:[{t:"Checkout: SP Tulsian\u0026#39;s views on Dish TV, Alembic Pharma, sugar",u:"http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html",s:"Moneycontrol.com",sp:"Sonia: From the pharma space Alembic Pharma is one stock I wanted to ask you about because you had been bullish on that stock for a while and the numbers look quite good for the company, a profit of growth of almost 50 percent, is this the stock that ...",d:"Jul 29, 2016",tt:"1469801701",usg:"AFQjCNFJXyjGiWv9KVWknNIOLGfGFlC6yQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/stocks-views/checkout-sp-tulsians-viewsdish-tv-alembic-pharma-sugar_7150081.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEjCb1RyzH7j6yy3mcLPGRwUHi3kQ"}],lead_story_doc_id:"15702015986716663660"},{idx:15,id:"0",lead_story_url:"http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html",a:[{t:"ICICI Sec initiates coverage on Alembic Pharma with add rating",u:"http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html",s:"Moneycontrol.com",sp:"Alembic Pharma is a vertically integrated pharmaceutical company with major focus on formulations business in India and US.",d:"Jul 18, 2016",tt:"1468835100",usg:"AFQjCNEsCrfh_11CQQvHx2M2qE0djLMpjw",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.moneycontrol.com/news/stocks-views/icici-sec-initiates-coveragealembic-pharmaadd-rating_7057821.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNEGL7d_u2JnS3jDqLY9GnxzId8w4w"}],lead_story_doc_id:"18045412946307932939"},{nrel:19,idx:16,id:"52779152501720",lead_story_url:"http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html",a:[{t:"Alembic Pharma, Cadila Healthcare gain on getting EIR from USFDA",u:"http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html",s:"Business Standard",sp:"Shares of Alembic Pharmaceuticals and Cadila Healthcare have rallied by up to 8% on the BSE in intra-day trade after these companies announced that they have received Establishment Inspection Report (EIR) from that US Food and Drug Administration\u0026nbsp;...",d:"Jul 8, 2016",tt:"1467966296",usg:"AFQjCNGkQK9KdxWQMj91EpDnpOSGdoU7ZA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.business-standard.com/article/markets/alembic-pharma-cadila-healthcare-gain-on-getting-eir-from-usfda-116070800385_1.html\u0026cid=52779152501720\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGZbSf6wmEzOnQ8jhXQw8RDAo243A"},{t:"Alembic Pharma shares surge over 7 per cent as Gujarat API unit gets USFDA EIR",u:"http://www.financialexpress.com/market/indian-markets/alembic-pharma-shares-on-bse-sensex-nse-nifty-on-july-8-2016/310525/",s:"Financial Express",sp:"Alembic Pharmaceuticals Ltd shares surged over 7 per cent intraday on Friday after the company said that it has received Establishment Inspection Report (EIR) from USFDA for the inspection carried out its Karakhadi API Plant III in April, 2015.",d:"Jul 8, 2016",tt:"1467965700",usg:"AFQjCNFYlApkTOtnEsQm1vu8rBpIk28vlg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.financialexpress.com/market/indian-markets/alembic-pharma-shares-on-bse-sensex-nse-nifty-on-july-8-2016/310525/\u0026cid=52779152501720\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF41nzOrX691jQKcZ_rhqXUIONu1Q"}],lead_story_doc_id:"17893708038863782210"},{idx:17,id:"0",lead_story_url:"http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1",a:[{t:"How the Amin family scions changed Alembic\u0026#39;s fortunes",u:"http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1",s:"Forbes India",sp:"Though the group\u0026#39;s real estate venture has nothing to do with its flagship listed pharmaceuticals business, the towering vertical structures are metaphoric of the equally vertical growth exhibited by Alembic Pharmaceuticals Ltd &#8212;one of India\u0026#39;s fastest ...",d:"Aug 4, 2016",tt:"1470277472",usg:"AFQjCNFC4JwxLAMWUTx5ovB5SZ74khTATQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.forbesindia.com/article/super-50-companies-2016/how-the-amin-family-scions-changed-alembics-fortunes/43951/1\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHagFzFQfwq9jhTWk9Vu52ZKijedA"}],lead_story_doc_id:"17410343117097814001"},{idx:18,id:"0",lead_story_url:"http://www.equitybulls.com/admin/news2006/news_det.asp?id=197079",a:[{t:"Alembic Pharmaceuticals receives USFDA Approval for Zolmitriptan Orally ...",u:"http://www.equitybulls.com/admin/news2006/news_det.asp?id=197079",s:"Equity Bulls",sp:"Alembic Pharmaceuticals Limited has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg.",d:"Dec 6, 2016",tt:"1480997444",usg:"AFQjCNHqoXIqGwqFMf9U5U4oyQezVOYhiA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.equitybulls.com/admin/news2006/news_det.asp%3Fid%3D197079\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNElDVWoZNNn_7ri_0t8O945HPr5TA"}],lead_story_doc_id:"3225528078968639210"},{nrel:1,idx:19,id:"52779244595433",lead_story_url:"http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html",a:[{t:"Sebi clarifies on re-classification of promoter group",u:"http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html",s:"Livemint",sp:"Expressing its views on an application filed by Alembic Pharmaceutical Ltd, the regulator said such re-classification may be allowed by the stock exchanges under listing norms subject to certain compliances.",d:"Oct 17, 2016",tt:"1476722475",usg:"AFQjCNFBmnESrPP9_mrh7KO6MujbwgwR9w",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.livemint.com/Companies/KFfNNuAfy5CboQuzoHN5aO/Sebi-clarifies-on-reclassification-of-promoter-group.html\u0026cid=52779244595433\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNFj7WABzJRFWyKYwi7k3YgFNwPHVw"}],lead_story_doc_id:"10360916528757987895"},{nrel:1,idx:20,id:"52779280720590",lead_story_url:"http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1",a:[{t:"Pranav \u0026amp; Shaunak Amin: Living up to Alembic Pharma\u0026#39;s legacy",u:"http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1",s:"Forbes India",sp:"In 2010, the pharma business was carved out of Alembic Ltd, which is still listed on the bourses as an entity that houses the group\u0026#39;s real estate business.",d:"Nov 23, 2016",tt:"1479874121",usg:"AFQjCNGFirYqcsbnzdPkO4HUJjlsBs-uRg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.forbesindia.com/article/leadership-awards-2016/pranav-shaunak-amin-living-up-to-alembic-pharmas-legacy/44887/1\u0026cid=52779280720590\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHMoy3kuoflX_-qT7kaQfXxP-TRjw"}],lead_story_doc_id:"4074195192213512356"},{nrel:30,idx:21,id:"52779316719959",lead_story_url:"http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/",a:[{t:"Vadodara liquor party: Ex-IPL chairman Chirayu Amin among 261 booked",u:"http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/",s:"The Indian Express",sp:"A high profile pre-marriage liquor party at a farmhouse on the city outskirts was raided late on Thursday night and 261 people, including former IPL Chairman and Managing Director of the Alembic Pharmaceutical Ltd Chirayu Amin, were booked in this\u0026nbsp;...",d:"Dec 23, 2016",tt:"1482531525",usg:"AFQjCNFWU5df0Opc9Zr-p1_WEMwNnCvadA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://indianexpress.com/article/cities/ahmedabad/vadodara-liquor-party-ex-ipl-chairman-chirayu-amin-among-261-booked-4442536/\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGlaGonbVcDJAhYNB3T1xIZJp5LWQ"},{t:"Business leaders detained for consuming liquor in Gujarat",u:"http://www.thehindubusinessline.com/news/national/exipl-chief-business-leaders-detained-for-consuming-liquor-in-gujarat/article9442002.ece",s:"Hindu Business Line",sp:"The Vadodara rural police raided a farmhouse on the outskirts and detained 261 persons, including Chirayu Amin, former chairman of Indian Premiere League (IPL) and chairman of pharma player, Alembic Pharmaceuticals Ltd besides other leading\u0026nbsp;...",d:"Dec 23, 2016",tt:"1482496425",usg:"AFQjCNFDsmFnigNWnPIYOLkCgr5ABBv6MQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.thehindubusinessline.com/news/national/exipl-chief-business-leaders-detained-for-consuming-liquor-in-gujarat/article9442002.ece\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGbKiwyonv3bVjTJQ--vgLcYhnj-w"},{t:"Police busts booze party near Vadodara, 261 including former IPL chairman booked",u:"http://www.indiatvnews.com/news/india-police-busts-booze-party-near-vadodara-261-including-former-ipl-chairman-booked-362322",s:"India TV",sp:"Acting on a tip-off, Vadodara police on Thursday busted a pre-marriage booze party and 261 people, including former IPL Chairman and Managing Director of the Alembic Pharmaceutical Ltd Chirayu Amin, were booked in this connection. Among others\u0026nbsp;...",d:"Dec 24, 2016",tt:"1482570000",usg:"AFQjCNHp6DaILnE0fvxAit76P8o6vGgkXA",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiatvnews.com/news/india-police-busts-booze-party-near-vadodara-261-including-former-ipl-chairman-booked-362322\u0026cid=52779316719959\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHYvahRQof9Zf1xEpJqJqIx1l0xzw"}],lead_story_doc_id:"16905264914339455772"},{idx:22,id:"0",lead_story_url:"http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine",a:[{t:"Biggies bite dust, small firms shine | Ahmedabad NYOOOZ",u:"http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine",s:"NYOOOZ",sp:"Top corporates such as Adani Enterprises Ltd (AEL), Adani Power, Torrent Pharmaceuticals Ltd, Tor rent Power Ltd, Alembic Pharmaceuticals Ltd and Arvind Ltd offered negative returns to their shareholders.Share prices of Adani Ports and Special Economic\u0026nbsp;...",d:"Jan 2, 2017",tt:"1483336606",usg:"AFQjCNGid5ZMAFlyfKLaB7IESwDqV4iR5Q",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.nyoooz.com/ahmedabad/699179/biggies-bite-dust-small-firms-shine\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNHZ4J4k9hCAXnsffyZhHM8PYmas0g"}],lead_story_doc_id:"9469653977539435813"},{idx:23,id:"0",lead_story_url:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html",a:[{t:"Pharmaceuticals Newsletter - December 12 to 16, 2016",u:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ltraconazole Capsules, 100 mg.",d:"Dec 16, 2016",tt:"1481890275",usg:"AFQjCNGkVv3Z9gyAs89sBw8tuMtm06rVrg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-12-to-16-2016-116121600378_1.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNF708BPlqBKfvcwONEC8OtkT7y55Q"}],lead_story_doc_id:"5325849731044066663"},{nrel:14,idx:24,id:"52779306708017",lead_story_url:"https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr",a:[{t:"Cipla redraws Iran plans with new agreement, to invest Rs 121 cr",u:"https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr",s:"Real Time News, India",sp:"Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.",d:"Dec 15, 2016",tt:"1481770800",usg:"AFQjCNHnJomc2mjNKhQVaQMdFOIW0tvOmQ",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=https://rtn.asia/d-r/25647/cipla-redraws-iran-plans-new-agreement-invest-rs-121-cr\u0026cid=52779306708017\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNGrHKFDsM4_Tk2O9oehtIamb68u6Q"}],lead_story_doc_id:"14492314507761336533"},{idx:25,id:"0",lead_story_url:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html",a:[{t:"Pharmaceuticals Newsletter - December 05 to 08, 2016",u:"http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html",s:"Indiainfoline",sp:"Alembic Pharmaceuticals Limited announced that the company has received approval from the US Food \u0026amp; Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg.",d:"Dec 9, 2016",tt:"1481288133",usg:"AFQjCNGZ5R772ytzsJESXsXGtIw4TxQNQg",sru:"http://news.google.com/news/url?sa=T\u0026ct2=us\u0026fd=S\u0026url=http://www.indiainfoline.com/article/news-top-industry-newsletters/pharmaceuticals-newsletter-december-05-to-08-2016-116120900379_1.html\u0026cid=0\u0026ei=WJ5rWOGGHZPYuATI5a2wAw\u0026usg=AFQjCNES1WpE38zyCUFLjZipgT-R1xCDWQ"}],lead_story_doc_id:"1558386962020854717"},{idx:26,id:"-1"}],results_per_page:10,result_start_num:1,result_end_num:0,result_total_articles:34},related:{cols:[0,1,4,30,34,31,32,5,2,33,3],rows:[{id:"1402851",values:["APLLTD","Alembic Pharmaceuticals Ltd","602.00","+0.50","chg","0.08","","113.71B","NSE","1402851","APLLTD"]},{id:"13475323",values:["ALEMBICLTD","Alembic Limited","37.25","-0.25","chr","-0.67","","9.88B","NSE","13475323","ALEMBICLTD"]},{id:"6286747",values:["506260","Anuh Pharma Ltd","220.10","+3.00","chg","1.38","","5.55B","BOM","6286747","506260"]},{id:"8321085",values:["530317","Godavari Drugs Ltd","43.60","+1.10","chg","2.59","","328.73M","BOM","8321085","530317"]},{id:"16520755",values:["INDSWFTLTD","IND Swift Ltd.","5.80","0.00","chb","0.00","","294.64M","NSE","16520755","INDSWFTLTD"]},{id:"5262084",values:["MARKSANS","Marksans Pharma Limited","40.95","0.00","chb","0.00","","16.78B","NSE","5262084","MARKSANS"]},{id:"10147154",values:["NATCOPHARM","Natco Pharma Ltd.","583.00","-1.60","chr","-0.27","","100.89B","NSE","10147154","NATCOPHARM"]},{id:"13313409",values:["GLAXO","GlaxoSmithKline Pharmaceuticals Ltd.","2,743.45","+12.95","chg","0.47","","232.36B","NSE","13313409","GLAXO"]},{id:"3578659",values:["DRREDDY","Dr.Reddy's Laboratories Ltd","3,072.00","-11.40","chr","-0.37","","525.26B","NSE","3578659","DRREDDY"]},{id:"2456500",values:["WANBURY","Wanbury Limited","66.70","+2.90","chg","4.55","","1.35B","NSE","2456500","WANBURY"]},{id:"16546949",values:["531633","Lincoln Pharmaceuticals Ltd","188.50","-0.05","chr","-0.03","","3.80B","BOM","16546949","531633"]}],visible_cols:[0,1,4,30,34,31,32,5]},related_str:"1402851,13475323,6286747,8321085,16520755,5262084,10147154,13313409,3578659,2456500,16546949",perf:[{u:"/finance?q=NSE:APLLTD",name:"APLLTD",cp:"0.08",p:"602.00",cid:"1402851"}],t:"NSE:APLLTD: {LAST} {CHANGE} ({CHANGE_PCT}%) - Alembic Pharmaceuticals Ltd",ticker:"NSE:APLLTD",cid:"1402851"},stickyUrlArgs:"\u0026ei=WZ5rWOHIB5PLuATpk5GoAw",chart:{_5d:"EXCHANGE%3DNSE\nMARKET_OPEN_MINUTE=555\nMARKET_CLOSE_MINUTE=930\nINTERVAL=120\nCOLUMNS=DATE,CLOSE,VOLUME\nDATA=\nTIMEZONE_OFFSET=330\na1482896880,610.75,1\n1,608,27\n2,610.7,4\n3,608.35,57\n4,608.5,138\n5,605.55,193\n6,605.2,42\n7,607.2,6\n8,609.65,151\n9,606.55,106\n10,606.65,16\n11,607.95,35\n12,609.9,46\n13,609.3,9\n14,609.85,20\n15,609.85,9\n16,609.75,8\n17,612,287\n18,612.75,610\n19,611.3,143\n20,611.2,13\n22,610.1,46\n23,610.05,67\n24,610.3,66\n25,610,12\n27,610.05,6\n28,612.2,71\n29,611.05,76\n30,611.75,7\n31,611.95,6\n32,613,39\n33,613.4,297\n34,613.95,188\n35,613.25,238\n36,611.95,441\n37,611.75,105\n38,611.75,1\n39,611.8,9\n40,612,10\n41,612,3\n42,612,7\n43,613.05,2337\n44,613,27\n45,612.8,31\n46,612.75,18\n47,612.75,5\n48,612.7,38\n49,613.35,175\n50,612.9,19\n51,613,41\n52,612.9,17\n53,612.55,90\n54,613,2787\n55,612.5,807\n56,611.95,149\n57,611.95,8\n58,612.35,10\n59,611.95,6\n60,611.95,3\n61,612,262\n62,611.85,17\n63,611.8,32\n64,611.55,19\n65,611.65,38\n66,611.6,7\n67,611.6,7\n68,611.55,6\n69,611.6,11\n70,612.3,965\n71,614.9,4017\n72,614.95,2447\n73,614.85,1200\n74,614.85,565\n75,613.85,231\n76,614.4,3296\n77,616.05,2125\n78,615,1068\n79,614.85,303\n80,614.85,146\n81,614.95,1412\n82,614,260\n83,613.95,13\n84,613.9,11\n85,613.9,9\n86,613.9,10\n87,613.85,9\n88,613.85,19\n89,613.95,810\n90,613.95,140\n91,614,2535\n92,614.3,337\n93,614.25,2\n94,614.05,28\n97,613.7,9\n98,613.5,23\n99,613.5,21\n100,613.25,11\n101,613,497\n102,613,35\n103,613.9,980\n104,614,1082\n105,613.95,1530\n106,614,72\n107,613.95,220\n108,613.95,3\n109,613.8,369\n110,612.65,292\n111,612.65,32\n112,612.05,11\n113,612.05,6\n114,612,6\n115,611.85,31\n116,611.75,10\n117,611.75,11\n118,612,75\n119,612,118\n120,612,9\n121,612,50\n122,612,11\n123,612.05,166\n124,611.95,22\n125,611.7,28\n126,611.7,18\n127,611.65,67\n128,612,197\n129,611.95,108\n130,611.95,35\n131,611.95,251\n132,611.95,2\n133,611.9,15\n134,611.85,8\n135,611,96\n136,610.05,674\n137,610,132\n138,610.3,148\n139,610.4,18\n140,610.3,87\n141,611.7,242\n142,611.5,25\n143,612.05,323\n144,612.05,84\n145,611.75,306\n146,611.75,36\n147,611.45,59\n148,611,74\n149,610.55,31\n150,610.95,201\n151,610.45,419\n152,610,82\n153,609.95,54\n154,610,345\n155,610,84\n156,610,55\n157,610,49\n158,610,75\n159,609,133\n160,609.15,2567\n161,609.15,88\n162,609.2,32\n163,609.2,627\n164,609,59\n165,609.2,406\n166,609,2179\n167,609,589\n168,609,796\n169,609,280\n170,609,302\n171,609.05,278\n172,609.45,265\n173,610.1,511\n174,609.9,372\n175,609.7,411\n176,609,164\n177,609.6,178\n178,609.6,50\n179,609.65,56\n180,609.65,96\n181,609.5,155\n182,609.65,143\n183,610,1283\n184,610,288\n185,610.8,1869\n186,612,124\n720,610.35,2\n721,611.95,68\n722,612.4,20\n723,612.3,1\n724,613.4,5\n725,612.6,20\n727,611.7,58\n728,611.7,5\n729,612.4,52\n730,612.05,134\n733,612,26\n734,609.05,126\n735,608.35,28\n736,608.05,1\n737,608.45,25\n738,609.8,126\n740,610,282\n741,609.6,96\n742,610,62\n743,610,33\n744,610,21\n746,609.6,79\n747,609.6,451\n748,609.45,48\n749,609.45,32\n750,609.2,9\n751,609.1,7\n752,609.2,60\n753,609.15,65\n754,609.1,7\n755,608.95,1\n756,608.95,10\n757,609,25\n758,608.7,12\n760,609,11\n761,609.5,25\n762,609.5,16\n763,609.05,28\n764,608.95,5\n765,608.75,51\n766,607,192\n767,607.05,20\n768,607,11\n771,608,65\n772,607,13\n773,606.5,67\n774,605.9,51\n775,607,10054\n777,607,30\n780,607,91\n781,609.4,26\n782,609.55,204\n783,609.45,5\n785,609.45,48\n790,609.45,5\n793,609,38\n794,607.35,12\n795,607.35,28\n797,607.4,44\n802,608.4,8\n803,608.9,7\n805,608.9,27\n806,609,50\n807,608,250\n811,608.9,5\n812,609.25,6\n814,608.25,9\n815,608,50\n820,607.55,239\n821,607.4,105\n822,607.4,5\n823,607.45,25\n824,604,551\n825,604,394\n826,603.5,327\n827,604,166\n828,603.95,107\n829,605.4,25\n830,603.75,51\n831,607.2,64\n833,607.15,3\n834,606.05,18\n836,604,654\n837,604,125\n838,603.55,21\n839,604,108\n840,604,89\n841,606.1,112\n843,606.1,7\n844,604.2,40\n845,606.05,2\n847,606.05,5\n849,607.55,319\n850,606.55,10\n851,606.55,10\n852,606.6,10\n855,606,10\n856,606,1\n858,606,243\n859,606.4,837\n860,606,51\n861,605.05,144\n863,605.7,20\n864,605.1,14\n866,605.8,30\n868,605,141\n869,605.7,54\n871,605.7,9\n872,605.6,307\n873,605.75,3\n874,605.85,8\n875,605.85,7\n876,605.75,207\n877,606,37\n878,605.7,181\n879,604.7,464\n880,605,843\n881,604.65,536\n882,603,1566\n883,603.9,7\n884,604,1794\n885,604,86\n886,604,147\n887,603.75,14\n888,603.2,137\n889,602.55,317\n890,603.95,134\n891,604.95,499\n892,605,270\n893,604.35,141\n894,604,90\n895,604.3,418\n896,603.5,144\n897,603,86\n898,601,9604\n899,601.8,403\n900,601.8,595\n901,602.15,58\n902,603,113\n903,603.05,64\n904,603.05,294\n905,603.5,705\n906,606.3,384\na1483069560,604.1,14\n1,606.7,1\n2,607,65\n3,607.9,44\n5,609.05,54\n6,610.85,353\n7,612.5,753\n8,611.65,20\n9,609.1,75\n10,609.05,70\n11,608,95\n12,608.9,6\n13,610,100\n14,609.6,40\n15,606.4,178\n16,606.3,169\n17,606.25,180\n18,608.05,294\n19,606.3,167\n20,605.6,214\n21,606,158\n22,605.65,241\n23,606.15,166\n24,607.25,243\n25,606,460\n26,606,275\n27,606,163\n28,605.55,172\n29,605.05,204\n30,605,732\n31,606.25,64\n32,606.65,2\n33,607,42\n36,607.05,47\n37,607,554\n38,607.45,2\n42,607,22\n43,607.35,1\n45,608,59\n46,611.35,518\n47,607.7,331\n48,605.9,87\n49,605.4,16\n50,604.1,119\n51,604.75,30\n52,605,124\n53,605.45,41\n54,605.2,32\n55,605.05,41\n56,605.4,17\n57,604.65,167\n58,604.65,136\n59,605.45,102\n60,605.35,16\n61,605.35,6\n63,605.75,4\n64,605.3,543\n65,605,586\n66,605,146\n68,604.65,2\n70,605,207\n73,605,12\n74,605,224\n75,605,48\n76,605,2\n77,605,100\n79,605,228\n80,605,379\n81,604.55,110\n83,604.7,63\n84,604.6,8\n85,605,100\n86,604.35,31\n87,604.9,245\n90,603.5,200\n93,604.6,4\n95,604.8,52\n96,604.9,24\n97,604.9,50\n98,604.65,1\n100,604.9,6\n102,604.9,191\n103,604.95,8\n105,605,100\n106,605,165\n108,604.7,280\n109,605,25\n111,604,75\n113,603.3,80\n114,604.35,24\n119,604.3,6\n120,604.3,2\n122,604,84\n125,603.9,46\n126,604.3,10\n128,605,387\n129,604.75,134\n130,604,161\n131,604,57\n132,604,97\n133,604,103\n134,604,65\n135,604,88\n136,604,226\n137,604,62\n138,603.95,148\n139,604,58\n140,603.9,818\n141,602,606\n142,602.3,840\n143,602,534\n144,602.15,309\n145,602.1,84\n146,602,362\n147,602.15,99\n148,601.95,72\n149,602.15,408\n150,602.05,676\n151,602,151\n152,602.1,1313\n153,601.9,359\n154,601.95,98\n155,599.5,1667\n156,598.75,277\n157,597.75,612\n158,597.95,239\n159,597.95,398\n160,599.35,1245\n161,600,1051\n162,600,1765\n163,600.4,396\n164,600.05,254\n165,599.95,256\n166,600.4,358\n167,600.15,266\n168,600,1172\n169,599.9,479\n170,599.95,273\n171,600.1,256\n172,600,629\n173,600,249\n174,600.35,376\n175,600,402\n176,600.4,277\n177,600.4,788\n178,600,232\n179,600.35,651\n180,600,241\n181,600,316\n182,596.5,2460\n183,595.05,4933\n184,590.05,3677\n185,593.45,2369\n186,591.95,606\n187,593.95,1065\na1483328760,601.2,42\n1,604,102\n2,605.65,653\n3,602.8,1\n4,604.9,6\n5,604.9,25\n6,603.9,4\n7,604,2\n8,603.05,3\n9,603.15,32\n10,602.95,56\n11,602.05,50\n12,601.7,45\n13,601.7,14\n14,602.5,127\n15,602.95,96\n16,602.95,85\n17,603.2,103\n18,600.05,562\n19,601.65,10\n21,600.3,59\n24,599.45,1\n26,599.95,202\n29,598.3,13\n30,598.95,117\n32,598.9,8\n33,597.5,81\n34,597.95,12\n35,597.95,5\n37,598,10\n39,597.95,20\n40,597.55,15\n41,597.55,145\n43,597.6,11\n44,598.1,7\n45,598.85,23\n46,599.95,67\n47,599.7,20\n49,600.85,50\n50,599.85,1\n51,600.9,15\n52,600.2,2\n53,599.75,109\n54,600.5,53\n55,600.5,3\n56,600,18\n58,599.1,115\n60,599,48\n61,600.5,39\n62,600.95,71\n64,601,112\n65,601.05,20\n66,601,52\n67,601,16\n69,601.95,26\n70,602,160\n71,602,7\n72,602,14\n73,602,5\n75,602,18\n76,602,60\n77,601.35,60\n78,601.95,2\n80,602.8,616\n81,603.85,302\n82,603.6,101\n83,602.85,286\n85,602.1,107\n86,602.15,3\n88,603.35,5\n89,603.25,50\n91,602.1,178\n92,603.4,36\n93,603.35,2\n95,603.35,19\n97,603.3,13\n100,603.3,75\n101,603,130\n102,602.65,10\n103,602.95,4\n104,602.65,7\n106,602.65,4\n109,602.1,50\n110,602.15,10\n111,602,519\n113,602,69\n115,602,350\n116,602,298\n117,602,15\n118,601,400\n121,601,8\n122,602,132\n126,601.1,3\n128,601.95,3\n129,601.95,10\n131,601.95,26\n135,601.95,10\n137,601.15,7\n138,602,144\n140,602,94\n141,602,55\n142,601.05,511\n143,601.95,302\n144,601,190\n145,601,50\n147,601.5,2\n148,601.5,12\n149,601,100\n151,601.75,43\n152,601.05,9\n157,601,50\n159,603.3,536\n160,603,188\n161,603,532\n163,602,340\n164,602,65\n165,603.5,550\n166,603.55,4\n168,602.05,212\n172,602,15\n173,601,27\n175,601,25\n176,601.75,657\n177,601.2,502\n178,602.45,310\n179,600.7,50\n181,600,560\n182,602,84\n183,604.95,1022\n184,602,260\n185,602,41\n187,600,345\n720,604.7,15\n721,604.5,30\n724,601,50\n725,600.65,20\n726,600.65,25\n727,601.7,28\n728,600.75,30\n730,601.55,169\n731,601.85,9\n732,601.85,22\n733,601.85,9\n734,600.05,71\n735,601.4,127\n736,601.7,330\n738,601.35,25\n739,601.05,66\n740,601.05,37\n744,602.25,24\n745,602.55,45\n746,602.45,88\n748,602.55,6\n749,602.45,93\n750,602.7,124\n751,603.1,36\n754,602.6,68\n755,602.5,10\n756,602.1,46\n757,602.1,14\n758,602.15,36\n759,602.15,11\n760,601.7,54\n761,601.85,39\n762,601.65,23\n763,602.85,148\n764,601.55,69\n765,601.5,167\n766,602,448\n767,602.05,70\n768,602.1,85\n769,602,91\n770,602,49\n771,602.05,142\n772,602.45,10\n773,602.35,736\n774,602,2410\n775,602,47\n776,602.5,250\n777,602,28\n778,602,1659\n780,602.5,7\n781,602,332\n782,602,13\n783,602,97\n784,602,89\n785,602,370\n786,602,43\n787,602,101\n788,602,105\n789,602,60\n790,602,158\n791,602,94\n792,602,59\n793,602,93\n794,602.05,59\n795,602,145\n796,602,36\n797,602,99\n798,602,54\n799,602,96\n800,602.05,237\n801,602,14\n802,602,27\n803,602,39\n805,602,1050\n806,602,31\n808,602,38\n809,602,16\n810,602,37\n811,602,22\n812,602,157\n813,602,2135\n814,602,39\n815,602.15,153\n816,602.1,16\n818,602.05,19\n819,602.05,24\n820,602,58\n821,602,31\n822,602.05,31\n823,602,49\n824,602,41\n825,602,50\n826,602,50\n827,602,46\n829,602.25,107\n830,602.5,31\n831,602.1,47\n832,602.6,18\n833,602.5,125\n835,602.5,2\n837,602.15,718\n838,602,591\n840,602,15\n841,602.05,39\n842,602,385\n843,602,37\n844,602,32\n845,602.1,99\n846,602.1,55\n847,602.2,28\n848,602,1039\n849,603.35,476\n850,603.35,10\n851,603.3,24\n854,602,2057\n855,602.05,43\n856,602.05,38\n857,602.05,63\n858,602.2,161\n859,602.1,37\n860,602.05,29\n861,602.15,374\n862,602.1,101\n863,602.1,30\n864,602.1,83\n865,602.05,30\n866,602.25,138\n867,602.2,4\n869,602,19\n870,602,110\n871,602.15,195\n872,601.95,262\n873,602,235\n874,602.05,805\n875,602.05,261\n876,602.05,445\n877,602.05,519\n878,602,62\n879,602,134\n880,602,330\n881,602,68\n882,602,105\n883,602,287\n884,601.7,111\n885,602.05,132\n886,602.05,187\n887,602,105\n888,602,46\n889,602.05,95\n890,602,28\n891,602.1,812\n892,602.3,160\n893,602.25,32\n894,602,82\n895,602.9,151\n896,602.25,17\n897,602.2,32\n898,602.2,74\n899,602,120\n900,602,90\n901,602.05,225\n902,602,253\n903,602.1,309\n904,602,4623\n905,602,1636\n906,602,1397\n907,602,448\n",_5Y:"EXCHANGE%3DNSE\nMARKET_OPEN_MINUTE=555\nMARKET_CLOSE_MINUTE=930\nINTERVAL=604800\nCOLUMNS=DATE,CLOSE,VOLUME,CDAYS\nDATA=\nTIMEZONE_OFFSET=330\na1325922300,36.85,58335,6\na1326448800,38,180425,6\n1,37.55,226059,5\n2,38.5,172198,4\n3,41.55,133952,5\n4,42.6,496024,5\n5,47,1025923,5\n6,46.3,387650,4\na1330760700,46.25,299908,5\na1331287200,44.75,235921,5\n1,43.5,344532,5\n2,45.85,241753,5\n3,48.9,275251,5\na1333533600,53.6,467129,5\na1334311200,56.8,354384,5\n1,57,717548,5\n2,54.5,700962,5\n3,52.25,318724,5\n4,52,406637,5\n5,49.4,244336,5\n6,49.8,209749,5\n7,48.75,84252,5\n8,49,29161,5\n9,53.7,532204,5\n10,54.8,468149,5\n11,55.5,342794,5\n12,57.45,909687,5\n13,57.3,283944,5\n14,58.15,23403,5\n15,60,901778,5\n16,64.5,612250,5\n17,58.7,1176813,5\n18,62.75,751910,4\n19,73.2,1625892,4\n20,68.6,1049524,5\na1347090300,75.5,1317196,6\na1347616800,73.1,1093448,6\n1,71.25,703622,4\n2,72,1147996,5\n3,70.3,500886,4\n4,69.9,355427,5\n5,69.95,616626,5\n6,69.1,86539,4\n7,68.1,333608,5\n8,68.25,372873,5\n9,66.35,333311,5\n10,62.05,501406,5\n11,63.45,307797,4\n12,65,402739,5\n13,68.1,468167,5\n14,67.35,384167,5\n15,69,195139,4\n16,72,813848,5\n17,71.2,553299,5\n18,71.35,427253,5\n19,70.9,1095051,5\n20,76.25,1876173,5\n21,74.05,358057,5\n22,76.8,377980,5\n23,77.3,221068,5\n24,82.5,707151,5\n25,99.2,2940215,5\n26,98.85,2073325,5\n27,104.25,1149530,5\na1364464800,103.5,409252,5\na1365156000,114.65,854360,5\n1,107.75,585631,5\na1366279200,117.1,750196,5\na1366970400,110.25,458671,5\n1,123,1708754,5\n2,122.15,646058,5\n3,131.05,1238334,5\n4,118,638971,5\n5,134,3008804,5\n6,143.5,1428849,5\n7,131.95,1325685,5\n8,133.15,1474429,5\n9,132.2,1371007,5\n10,147.2,1411123,5\n11,158.8,2319684,5\n12,164,907621,5\n13,151.25,454122,5\n14,141.5,1360032,5\na1375956000,156.3,1625546,5\na1376647200,144.7,480594,5\n1,142,633701,5\n2,133.5,482191,5\n3,135,500628,5\n4,139.6,669039,5\n5,136.8,283198,5\n6,141.45,788805,5\n7,150,390430,5\n8,175,1899291,5\n9,168,536859,5\n10,179.35,1191856,5\n11,195,2374522,5\n12,205,1358431,5\n14,199.5,498663,5\n15,204.55,522640,5\n16,205.35,630912,5\n17,193.35,390834,5\n18,211.25,1355169,5\n19,211.15,595924,5\n20,211,274012,5\n21,222.2,2022127,5\n22,219.8,992401,5\n23,222.25,2235990,5\n24,221.5,717731,5\n25,230.9,623203,5\n26,232.95,570450,5\n27,248.2,915073,5\n28,267.75,941945,5\n29,282,2061540,5\n30,276.9,2444222,5\n32,282.8,1034066,5\n33,280.55,832444,5\n34,275.35,766165,5\na1397728800,269.75,242950,5\na1398420000,306.4,1900741,5\n1,296.25,1684533,5\n2,273,557203,5\n3,257,1137890,5\n4,238.8,1890338,5\n5,246.4,656991,5\n6,241.9,922044,5\n7,271.1,1731101,5\n8,277.15,817074,5\n9,269,455065,5\n10,310,2553138,5\n11,305,1236139,5\n12,337.9,1381597,5\n13,331,1453618,5\n14,336.75,1571253,5\n15,341.75,1676087,5\na1408010400,353,809566,5\na1408701600,386,1456797,5\na1409220000,370.15,825347,5\na1409911200,395.6,1948962,5\n1,430,1071688,5\n2,421.55,1044558,5\n3,414,1024992,5\na1412157600,416,496703,5\na1412935200,388,523722,5\n1,388.05,945870,5\na1414058400,423,1120555,5\na1414749600,406,592578,5\n1,407.2,436137,5\n2,448,1530240,5\n3,437,693077,5\n4,422.5,504419,5\n5,443.4,1057417,5\n6,432.5,337830,5\n7,423.45,346337,5\n8,425.55,212805,5\n9,458,376544,5\n10,473,976409,5\n11,459.05,356425,5\n12,475,623019,5\n13,469.1,554189,4\n14,422.75,1571020,5\n15,424.15,1886177,5\n16,423.85,574459,4\na1425119400,405,1380916,6\na1425549600,431,1109952,5\na1426240800,446,951123,5\n1,450,1009715,5\n2,447.05,486740,5\na1427882400,454,286253,5\na1428660000,485,636682,5\n1,484,710398,4\n2,486,683582,5\na1430388000,471.4,1997787,5\na1431079200,470.55,656335,5\n1,497.05,880403,5\n2,540.15,1289955,5\n3,554,404925,5\n4,555.4,932765,5\n5,564.3,837604,5\n6,667,2164251,5\n7,659,1596868,5\n8,680,1250588,5\n9,757,1988349,5\n10,759.55,864295,5\n11,753,622017,5\n12,715.8,1694853,5\n13,705.2,1021003,5\n14,703.75,946796,5\n15,710,492220,5\n16,702.5,612443,5\n17,678,548906,5\n18,665,566354,5\n19,684,337354,4\na1443088800,675,402460,4\n1,705,825537,5\na1444384800,724,678380,5\n1,717,520707,5\n2,693.1,237550,4\n3,677.9,2876982,5\n4,671,638596,5\n5,663.2,217865,4\n6,659,494843,5\n7,691.95,502735,4\n8,684,404086,5\n9,661.75,296988,5\n10,678,253916,5\na1450951200,698,547024,5\na1451642400,686,577317,5\n1,667.25,290582,5\n2,619.9,566180,5\n3,630,1397575,5\n4,619.5,961645,4\n5,590,1164483,5\n6,586.05,465757,5\n7,617.9,445220,5\n8,608,232541,5\n9,640,458241,5\n10,615.05,242895,4\n11,610,258202,5\na1458727200,609,297188,5\na1459504800,592,1097991,5\n1,553.1,522021,5\na1460541600,561.3,264813,4\na1461319200,617.85,1362901,4\n1,600,2045733,5\n2,594.6,695708,5\n3,583,462025,5\n4,563,424980,5\n5,540,475531,5\n6,558,668337,5\n7,562.85,201855,5\n8,528.4,563493,5\n9,537,286337,5\n10,582.1,1036655,5\n11,598,862516,4\n12,575.6,277858,5\n13,588,236289,5\n14,627.2,1196803,5\n15,635.95,500271,5\n16,649.8,356772,5\n17,648,288167,4\n18,635,201312,5\n19,621.5,222007,5\n20,634,343122,4\n21,655,540908,4\n22,677.5,586674,5\n23,652.5,468346,5\n24,673.25,678597,5\n25,680.1,295689,3\n26,676,375790,5\n27,677,724775,5\n28,658,381269,5\n29,636.2,316834,5\n30,606,425976,4\n31,648,467788,5\n32,630.9,396528,5\n33,639,149277,5\n34,624,228748,5\n35,614.95,101171,5\n36,593.95,229382,5\n",corp_actions:"[{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1313466300\",\"_amount\":\"1.0\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1314675900\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1343706300\",\"_amount\":\"1.4\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1344570300\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1375069500\",\"_amount\":\"2.5\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1376451900\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1405568700\",\"_amount\":\"3\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1406605500\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1437536700\",\"_amount\":\"3.5\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1438919100\"},{\"_quote\":\"NSE:APLLTD\",\"_type\":\"dividend\",\"_date\":\"1468986300\",\"_amount\":\"4\",\"_amount_currency\":\"INR\",\"_payable_date\":\"1470368700\"}]",related_items:[{ticker:"NSE:ALEMBICLTD",name:"ALEMBICLTD",timezone_offset:19800,is_index:false},{ticker:"BOM:506260",name:"506260",timezone_offset:19800,is_index:false},{ticker:"BOM:530317",name:"530317",timezone_offset:19800,is_index:false},{ticker:"NSE:INDSWFTLTD",name:"INDSWFTLTD",timezone_offset:19800,is_index:false},{ticker:"NSE:MARKSANS",name:"MARKSANS",timezone_offset:19800,is_index:false},{ticker:"NSE:NATCOPHARM",name:"NATCOPHARM",timezone_offset:19800,is_index:false},{ticker:"NSE:GLAXO",name:"GLAXO",timezone_offset:19800,is_index:false},{ticker:"NSE:DRREDDY",name:"DRREDDY",timezone_offset:19800,is_index:false},{ticker:"NSE:WANBURY",name:"WANBURY",timezone_offset:19800,is_index:false}]}};
google.finance.data.numberFormat = [{'threshold':1000000, 'symbol':'M'}, {'threshold':1000000000,'symbol':'B'}, {'threshold':1000000000000,'symbol':'T'}] ;
_setStickyUrlParams("ei=WZ5rWOHIB5PLuATpk5GoAw");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
google.finance.renderRecentQuotes();
', 
', 
', 
', 
', 
', 
', 
', 
', google.finance.renderRelativePerformance();', 
', 
', 
', 
', 
', 
', 
', 
', 602.00', 
', 
', 
', +0.50', 
', (0.08%)', 
', 
', 
', 
', 
', 
Jan 3 - Close
', 
', 
', NSE
real-time data -
', Disclaimer', 
', 
', Currency in INR', 
', 
', 
', 
', 
', 
', 
', 
', Range
', 
', 600.05 - 605.05
', 
', 
', 
', 52 week
', 
', 512.50 - 699.00
', 
', 
', 
', Open
', 
', 602.35
', 
', 
', 
', Vol.
', 
', 36,777.00
', 
', 
', 
', Mkt cap
', 
', 113.71B
', 
', 
', 
', P/E
', 
', 19.46
', 
', 
', 
', Div/yield
', 
', 4.00/0.66
', 
', 
', 
', EPS
', 
', 30.94
', 
', 
', 
', Shares
', 
', 188.52M
', 
', 
', 
', Beta
', 
',     -
', 
', 
', 
', Inst. own
', 
',     -
', 
', 
', 
', 
', 
', 
', 
', 
', google.finance.renderMarketData();', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', News', 
', 
', 
', 
', 
', 
', Relevance', 
', 
', 
', 
', Date', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', All news for Alembic Pharmaceuticals Ltd »', 
', 
', Subscribe', 
', 
', 
', 
', 
', 
', 
', Advertisement', 
', 
', 
', Key stats and ratios', 
', 
', 
', 
', 
', u"Q3 (Sep '16)
", 2016
', 
', 
', Net profit margin
', 14.05%
', 22.74%
', 
', Operating margin
', 17.87%
', 29.52%
', 
', EBITD margin
', -
', 31.80%
', 
', Return on average assets
', -
', 35.38%
', 
', Return on average equity
', -
', 58.01%
', 
', Employees
', 8,007
', -
', 
', CDP Score
', -
', 
-
', 
', 
', 
More ratios from Thomson Reuters »', 
', 
', Address', 
', Alembic Road', VADODARA, 390003', India', +91-265-2282550 (Phone)', +91-265-2281508 (Fax)', 
', 
', Website links', 
', 
', 
http://www.alembic-india.com/
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Settings',  |
', Technicals',  |
', 
', 
', 
Link to this view', 
', 
', 
', 
', Sources include SIX.', 
', 
', 
', 
', 
', 
var _minZoomDays = 1;
var _minZoomDaysNoIntraDay = _minZoomDays;
var _timeZoneOffset = '19800';
_chartConfigObject = {};
_chartConfigObject.hasVolume = _displayVolume;
_chartConfigObject.hasNews = true;
_chartConfigObject.hasExtendedHours = false;
_chartConfigObject.hasDefaultZoomSetting = true;
_chartConfigObject.hasVerticalScaleSetting = true;
_chartConfigObject.displayVolume = 'true';
_chartConfigObject.displayNewsPins = 'true';
_chartConfigObject.displayDividends = 'true';
_chartConfigObject.displaySplits = 'true';
_chartConfigObject.displayExtendedHours = 'false';
_chartConfigObject.enableCustomDateEntry = true
_chartConfigObject.defaultZoomDays = '3';
_chartConfigObject.snapping = false;
_chartConfigObject.verticalScaling = 'maximized';
_chartConfigObject.sparklineType = 'dynamic';
// set _minZoomDays and _minZoomDaysNoIntraDay in each page before emit the
// chart to passing the value to chart, otherwise default value will be use.
_chartConfigObject.minZoomDaysNormal = _minZoomDays;
_chartConfigObject.minZoomDaysNoIntraDay = _minZoomDaysNoIntraDay;
_chartConfigObject.enableIndicator = true;
_chartConfigObject.companyId = '1402851';
_chartConfigObject.enableRealtimeChart = true;
_chartConfigObject.isMarketOpenState = 0;
_chartConfigObject.stateRemainingMinutes = 894;
_chartConfigObject.delayedMinutes = 0;
_chartConfigObject.enableChartTypeSetting = true;
_chartConfigObject.lineStyle = 'IntervalBasedLine';
_chartConfigObject.defaultInterval = '86400';
_chartConfigObject.enableIndicatorSetting = true;
_chartConfigObject.biasSetting = '';
_chartConfigObject.emaSetting = '';
_chartConfigObject.kdjSetting = '';
_chartConfigObject.macdSetting = '';
_chartConfigObject.rsiSetting = '';
_chartConfigObject.smaSetting = '';
_chartConfigObject.vmaSetting = '';
_chartConfigObject.cciSetting = '';
_chartConfigObject.williamsPercentRSetting = '';
_chartConfigObject.bollingerBandsSetting = '';
_chartConfigObject.fastStochasticSetting = '';
_chartConfigObject.slowStochasticSetting = '';
_chartConfigObject.expandButtonEnabled = true;
_chartConfigObject.companyCurrency = 'INR';
_chartConfigObject.displayDividendsUnits = 'false';
_external_target = "";
_emitFlashChart(
"/finance/s/n-VxNKK74DU/chart9.swf?hl=en&gl=us",
_ticker, _chartConfigObject,"http:\x2F\x2Fwww.google.com:80");
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Advertisement', 
', 
', 
', 
', 
', 
', 
', 
', Related companies', 
', 
', 
', 
', 
', 
Show:
', 
', 
Most Recent Quarter
', 
', 
Most Recent Annual
', 
', 
', 
', 
', Add or remove columns', 
', Save changes', 
', Cancel', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', More from FactSet »', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', 
', Description', 
', 
', 
', 
', 
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.
', 
', 
More from Reuters »
', 
', 
', 
', 
', u"_tck('aft');", 
', 
', 
', 
', Officers and directors', 
', 
', 
', 
', 
', 
', Chirayu R. Amin
', 
', Executive Chairman of the Board, Chief Executive Officer
', 
', 
', 
', 
', 
Age: 66', 
', 
', Rajkumar K. Baheti
', 
', Chief Financial Officer, Director - Finance, Executive Director
', 
', 
', 
', 
', 
Age: 54', 
', 
', Ajay Kumar Desai
', 
', Associate Vice President-Finance, Company Secretary and Compliance Officer
', 
', 
', 
', 
', 
', 
', Pranav Amin
', 
', Managing Director, Executive Director
', 
', 
', 
', 
', 
Age: 38', 
', 
', Shaunak Amin
', 
', Managing Director, Director
', 
', 
', 
', 
', 
', 
', Archana Hingorani
', 
', Additional Independent Director
', 
', 
', 
', 
', 
', 
', Milin Mehta
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', Pranav N. Parikh
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', K. S. Ramanathan
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', Paresh Saraiya
', 
', Non-Executive Independent Director
', 
', 
', 
', 
', 
', 
', 
', 
Full list on Reuters »', 
', 
', 
', 
', 
', 
', 
', 
', 
', Google Finance Beta available in: ', Hong Kong',  - ', Canada',  - ', U.S.',  - ', China',  - ', U.K.', Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.', To see all exchange delays, please ',  see disclaimer', .', ©2017 Google - ', Google Home',  - ', Blog',  - ', Help',  - ', Report a Problem',  - ', Privacy Policy',  - ', Terms of Service', 
', 
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = 'WZ5rWOHIB5PLuATpk5GoAw';
var _expid;
var _external_target;
var _localDomain = 'www.google.com';
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
_setStickyUrlParams("ei=WZ5rWOHIB5PLuATpk5GoAw");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
_regOnLoad(onCompanyLoad);
', 
', var googlefinance = {i: ["f.b.id","",null,0,"",0,null,["f.b.cf","9R147Dhnn8c.en_US.",0],[["1402851","Alembic Pharmaceuticals Ltd","APLLTD","NSE","APLLTD","602.00","up","+0.500","0.08","113.71B"]],1,[],"WZ5rWOHIB5PLuATpk5GoAw","www.google.com","xAuUpkokml0M7MT-UAOHAAB5nfg:1483447897282",1]}; GF_domReady = 1;']